Medline’da 1990 – 2020 arasında hakem denetiminden geçmiş toplamda 700 yayım
Google-scholar alıntılar: 39.074 (10 Aralık, 2020)
H-index: 95
i10 index: 554
1990:
J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Extragonadal germ cell tumor invading the prostate. Eur Urol. 1990; 18: 77-79.
A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, C.A.M. van Helvoort-van Dommelen, M.A.A.M. van Dijk, H. Semmelink, N.V.M. Rijntjes and F.M.J. Debruyne. Histologic analysis of ultrasonic images of the prostate: an accurate technique. Ultrasound in Med & Biol 1990; 16(7): 667-674.
1991:
J.J.M.C.H. de la Rosette, J.D.M. de Vries, M.T.W.T. Lock, F.M.J. Debruyne. Urethra plasty using the pedicled island flap technique in complicated urethral strictures. J Urol.1991; 146:40-42.
J.J.M.C.H. de la Rosette and F.M.J. Debruyne. Non-bacterial prostatitis: a comprehensive review. Urol Int. 1991; 46:121-125.
1992:
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, F.M.J. Debruyne. Ultrasonographic findings in patients with non-bacterial prostatitis. Urol Int. 1992; 48: 323-326.
J.J.M.C.H. de la Rosette, M.R. Hubregtse, H.F.M. Karthaus, F.M.J. Debruyne. Results of a questionnaire among dutch urologists and general practitioners concerning diagnostics and results of treatment of patients with prostatitis syndromes. Eur Urol. 1992; 22: 14-18.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de Boo, F.M.J. Debruyne. The use of alfuzosin, a new alpha receptor blocking agent, in patients with prostatodynia and voiding symptoms of an irritative nature. Urology 1992. 9: 215-219.
H.P. Beerlage, J.J.M.C.H. de la Rosette, A.J. Frima. Association between haematoma after inguinal hernia repair and site of heparin injection. Eur J Surg. 1992; 158 :287-288.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, Ph.E.V.A. van Kerrebroeck, Th. de Boo, F.M.J. Debruyne. Research in “prostatitis syndromes”: the use of alfuzosin (a new alpha-1-receptor blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol. 1992; 22(3): 222-227.
1993:
J.J.M.C.H. de la Rosette, M.R. Hubregtse, E.J.H. Meuleman, M.V.M. Stolk-Engelaar, F.M.J. Debruyne. Diagnostics and treatment of 409 patients with prostatitis syndromes. Survey of results. Urology 1993; 41: 301-307.
J.J.M.C.H. de la Rosette, M.C.M. Ruijgrok, J. Jeuken, H.F.M. Karthaus, F.M.J. Debruyne. Personality variables involved in chronic prostatitis. Urology1993; 42: 654-662.
J.J.M.C.H. de la Rosette, M.R. Hubregtse, J.M. Wiersma, F.M.J. Debruyne. The value of urine cytology in the screening of patients with prostatitis syndromes. Acta Cytologica. 1993; 37: 711-712.
J.J.M.C.H. de la Rosette, H.F.M. Karthaus, H.E. Schaafsma, R. van Dijk. Workup and management of incidentally found hypoechoic lesions of the testis. Urol Int 1993; 51: 23-27.
J.J.M.C.H. de la Rosette. Diagnostiek en behandeling van patiënten met prostatitis klachten: veranderde inzichten? Nederlands Tijdschrift voor Urologie 1993; 1: 7-10.
J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.M.J. Debruyne. Clinical results with microwave thermotherapy of benign prostatic hyperplasia. Eur Urol 1993; 23: 68-71.
J.D.M. de Vries, J.J.M.C.H. de la Rosette, E.J.K.J.E.M van Grunsven. Urethraplasty, using the preputial island flap technique: revisted. Eur Urol 1993; 24: 77-80.
R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated volume measurement of the prostate with AUDEX. J Endourol.1993; 7 (suppl. 1): S191.
1994:
J.J.M.C.H. de la Rosette. Microwave treatment of BPH: still an option? Arch Esp de Urol. 1994; 47(9): 889-894.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, G. Alivizatos, F.M.J.A. Froeling, F.M.J. Debruyne. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994; 44: 58-63.
F.M.J.A. Froeling, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Minimaal invasieve urologie: nieuwe ontwikkelingen van behandelingen in de urologie. NTVG 1994; 138(35): 1756-1760.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, F.A.G. Bloem. R. Laduc, F.M.J. Debruyne. Transurethrale microgolf thermotherapie (TUMT) bij de behandeling van benigne prostaat hyperplasie. NTVG 1994; 138(35): 1764-1770.
F.M.J.A. Froeling, M.J.G. Sorber, J.J.M.C.H. de la Rosette, J.D.M. de Vries. The non-palpable testis and the changing role of laparoscopy. Urology 1994; 43(2): 222-227.
R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, M.P. van Iersel, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. The reliability of computer/ analysis of ultrasonographic prostate images: the influence of inconsistent histopathology. Ultrasound in Medicine & Biology 1994; 20:871-876.
A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Analysis of ultrasonographic prostate images for the detection of prostatic carcinoma: the Automated Urologic Diagnostic EXpert system. Ultrasound in Med & Biol 1994; 20: 1-10.
G.J. Jager, J.O. Barentsz, J.J.M.C.H. de la Rosette, G. Rosenbusch. Preliminary results of endorectal surface coil magnetic resonance imaging for local staging of prostatic cancer. Radiologe 1994; 34: 129-133.
R.G. Aarnink, R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. A practical clinical method for contour determination in ultrasonographic prostate images. Ultrasound in Medicine and Biology 1994; 20: 705-717.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Retreatment rate after surgical and non-surgical treatments. Prog Clin Biol Res 1994; 386: 597-613.
J.J.M.C.H. de la Rosette, F.M.J.A. Froeling, G. Alivizatos, F.M.J. Debruyne. Laser ablation of the prostate: experience with an ultrasound guided technique and a procedure under direct vision. Eur Urol 1994; 25(1), 19-24.
J.J.M.C.H de la Rosette, A. Tubaro, K. Hofner, S.S. Carter. Transurethral microwave thermotherapy: past, present and future. World J Urol 1994; 12(6): 352-356.
1995:
J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, M.P. van Iersel, F.M.J. Debruyne, H. Wijkstra. Automated analysis and interpretation of transrectal ultrasonography images in patients with prostatitis. Eur Urol 1995; 27: 47-53.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne, P.L. Kersten, H. Wijkstra. Reliability of uroflowmetry investigations: results of a portable homeflowmetry study. Neurourology and urodynamics 1995; 14: 534-536.
J.J.M.C.H. de la Rosette, R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Computerized analysis of transrectal ultrasonography images in the detection of prostate carcinoma. Br J Urol 1995; 75: 485-491.
J.J.M.C.H. de la Rosette, E. Te Slaa, M.J.A.M. de Wildt, F.M.J. Debruyne. Experience with the Ultraline and Urolase laser fibers: is there any difference? World J Urol 1995; 13: 98-103.
J.J.M.C.H. de la Rosette, A. Tubaro, A. Trucchi, S.St.C. Carter, K Hofner. Changes in pressure-flow parameters in patients treated by TUMT (version 2.0). J Urol 1995; 153: 1526-1536.
M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette. Transurethral microwave thermotherapy: an evolving technology in the treatment of benign prostatic enlargement. Br J Urol 1995; 76: 531-538.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, E.L. Koldewijn, F.M.J. Debruyne, H. Wijkstra. Variability of pressure flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia. J Urol 1995; 153: 1520-1525.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette. Is there a correlation between prostate size and bladder-outlet obstruction? World J Urol 1995; 13: 9-13.
P.F.W.M. Rosier, M.J.A.M. de Wildt, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Analysis of Maximum Detrusor Contraction Power in Relation to bladder emptying in patients with lower urinary tract symptoms and benign prostatic enlargement. J Urol 1995; 154: 2137-2142.
M.P. van Iersel, W.P.J. Witjes, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. Br J Urol 1995; 76: 47-53.
R.G. Aarnink, R.J.B. Giesen, J.J.M.C.H. de la Rosette, A.L. Huynen, F.M.J. Debruyne, H. Wijkstra. Planimetric volumetry of the prostate: how accurate is it? Physiol Meas 1995; 6:141-150.
Tubaro, S.St.C. Carter, J.J.M.C.H. de la Rosette, K Hofner, A. Trucchi, C. Ogden, L. Miano, M. Valenti, U. Jonas, F.M.J Debruyne. The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a european multicenter study. J Urol 1995; 153:1526-1530.
R.J.B. Giesen, A.L. Huynen, J.J.M.C.H. de la Rosette, H.E. Schaafsma, R.G. Aarnink, F.M.J. Debruyne, H. Wijkstra. Ultrasonic computer imaging of the prostate, correlation between longitudinal and transverse texture description. Eur J Ultrasound 1995; 2: 145-149.
J. Donovan, H. Kay, P. Abrams, J.J.M.C.H. de la Rosette, S Brookes, A.C. Kinn and the ICS-BPH study Group. Measuring Quality of life in men with urinary symptoms: using the SF-36.Neurourology and urodynamics 1995; 14:559-560.
M. Devonec, S.St.C. Carter, A Tubaro, J.J.M.C.H. de la Rosette, K Hofner, P. Perrin. Microwave therapy. Current Opinion 1995; 5: 3-9.
R.J.B Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, C. van de Kaa, G.O.N Oosterhof, F.M.J Debruyne, H. Wijkstra. Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 1995; 154: 1397-1400.
R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated prostate volume determination with ultrasonographic imaging. J Urol 1995; 153:1549-1554.
M.J.A.M. de Wildt, A. Tubaro, K Hofner, S.St.C. Carter, J.J.M.C.H. de la Rosette, M. Devonec. Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol 1995; 54:1775-1778.
E. te Slaa, A.F. van Ettergem, C.A. van ‘t Hof, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Durability of laser fibers. World J Urol 1995; 13: 83-87.
A. Cannon, M. de Wildt, P.H. Abrams, J.J.M.C.H. de la Rosette. Urodynamics and laser prostatectomy. World J Urol 1995; 13:134-136.
E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urinary tract infections following laser prostatectomy: is there a need for antibiotic prophylaxis? Br J Urol 1995; 76: 604-610.
E. te Slaa, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic assessment in the laser treatment of benign prostatic enlargement. Br J Urol 1995; 76: 604-610.
P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Outcome of treatment of patients with lower urinary tract symptoms that are categorized ‘moderately obstructed’, according to the L-PURR classification and ‘not-obstructed’ according to urethral resistance factor. Neurourology and urodynamics 1995; 14: 562-564.
M.J.A.M. de Wildt, E. te Slaa, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved? J. Urol 1995; 154: 174-180.
P.F. Rosier, J.J.M.C.H de la Rosette, H. Wijkstra, P.E. Van Kerrebroeck, F.M.J. Debruyne. Is detusor instability in elderly males related to the grade of obstruction? Neurourol Urodyn 1995; 14(6): 625-633.
J.J.M.C.H. de la Rosette, J.M. Fitzpatrick. The laser in the management of benign prostatic hyperplasia. World J Urol 1995; 13(2): 73.
1996:
M.J.A.M. de Wildt, M. Hubregtse, G. Ogden, S.S.C. Carter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. A 12-months study of the placebo effect in transurethral microwave thermotherapy. Br.J.Urol 1996; 77: 221.
P.F.W.M. Rosier, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Evaluation of detrusor activity during micturition in patients with benign prostatic enlargement with a clinical nomogram. J. Urol 1996; 156: 473-479.
J.J.M.C.H. de la Rosette, W.P.J. Witjes, F.M.J. Debruyne, P.L. Kersten, H. Wijkstra. Improved reliability of uroflowmetry investigations: results of a portable home-based flowmetry study. Br.J.Urol. 1996; 78: 385-390.
J.J.M.C.H. de la Rosette. Evaluatie van de mictie met behulp van uroflowmetry: het gebruik van een portable homeflowmeter. Profundum 1996; 3: 24-27.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K. Hofner, S.St.C. Carter, F.M.J. Debruyne, A. Tubaro. Pressure/flow study analysis in patients treated with High Energy Thermotherapy (Prostasoft 2.5). J.Urol. 1996; 156: 1428-1433.
J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, K Hofner, S.St.C. Carter, F.M.J. Debruyne, A. Tubaro. High energy thermotherapy in the treatment of benign prostatic hyperplasia. Results of the European BPH study group. J.Urol. 1996; 156: 97-102.
R. Muschter, J.J.M.C.H. de la Rosette, H. Whitfield, J-P Pellerin, S. Madersbacher and D. Gillatt. Initial Human Clinical Experience with Diode Laser Interstitial Treatment of BPH. Urology 1996; 48: 223-228.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra: Reproducibility of transrectal ultrasound of the prostate concerning planimetric volume determinations. Br. J. Urol. 1996; 78: 219-223.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula derived prostate volume determination. Eur Urol 1996; 29: 399-402.
R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J. Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of prostate volume, Part I: morphometry in patients with lower urinary tract symptoms. The Prostate 1996; 9(5): 317-326.
R.G. Aarnink, J.J.M.C.H. de la Rosette, A.L. Huynen, R.J.B. Giesen, F.M.J. Debruyne, H. Wijkstra. Standardized assessment to enhance the diagnostic value of prostate volume, Part II: correlation with PSA levels. The Prostate 1996; 29(5): 327-333.
E. te Slaa, J.J.M.C.H. de la Rosette. Lasers in the treatment of benign prostatic obstruction: past, present and future. Eur. Urol. 1996; 30: 1-10.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, H. Wijkstra, Ph.E.V.A. van Kerrebroeck, F.M.J. Debruyne. Is detrusor instability in elderly males related to the grade of obstruction. Neuro Urol Urodyn 1996 14: 625-635.
P.F.W.M. Rosier, J.J.M.C.H. de la Rosette, M.J.A.M. de Wildt, F.M.J. Debruyne, H. Wijkstra. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement. Neuro Urol Urodyn. 1996; 15: 1-15.
K. Ezz El Din, J.J.M.C.H. de la Rosette. Transrectal ultrasound of the prostate. Br.J.Urol. 1996; 78: 2-9.
M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. Urology 1996; 48: 416-423.
G.J. Jager, J.O. Barentz, E.T.G. Ruijter, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Primary staging of prostate cancer. Eur.Radiol. 1996; 6: 129-133.
C.F.P van Swol, E. te Slaa, R.M. Verdaasdonk, J.J.M.C.H. de la Rosette, T.A. Boon. Variation in output power of laser prostatectomy fibers: a need for power measurement. Urology 1996; 47: 672-678.
G.J. Jager, E.T.G. Ruijter, C.A. van de Kaa, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof, J.R. Thornbury, J.O. Barentz. Local Staging of Prostate Cancer with Endorectal MR imaging: Correlation with Histopathology. A.J.R. 1996; 66: 845-852.
R.J.B. Giesen, A.L. Huynen, R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Construction and application of a hierarchical decision tree for the classification of ultrasonographic prostate images. Medical & Biological Engeneering & Computing 1996; 34:105-109.
W.F.R.M. Koch, K. Ezz El Din, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. J Urol 1996; 155: 186-189.
M.P. van Iersel, C.M.G. Thomas, W.P.J. Witjes, R. de Graaf, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Clinical implications of the rise and fall of PSA after laser prostatectomy. Br.J.Urol. 1996; 78: 742-746.
P.F.W.M. Rosier, M.J.A.M. de Wildt, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction. J. Urol. 1996; 155:1649-1654.
K. Ezz El Din, M.J.A.M. de Wildt, P.F.W.M. Rosier, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between urodynamic and cystoscopic findings in elderly men with voiding complaints. J Urol 1996; 155: 1018-1022.
K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Reliability of the international prostate symptom score (IPSS) in the assessment of patients with lower urinary tract symptoms and/or benign prostatic enlargement. J Urol. 1996; 155: 1959-1964.
A. Jardin, K.E. Andersson, C.C. Schulman, D. Graham, J.M. Buzelin, J.J.M.C.H. de la Rosette, T. Christmas, C.R. Chapple. Consensus Meeting on New approaches in the Pharmacotherapy of Benign Prostatic Hyperplasia (BPH). Eur Urol 1996; 29:374-384.
J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H. de la Rosette and A. Kondo. The ICS - ‘BPH’Study: the psychometric validity and reliability of the ICS male questionnare. Br.J.Urol. 1996; 77: 554-562.
M.J.A.M. de Wildt, F.C.H. d’Ancona, M. Hubregtse, S.St.C. Carter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. 3 Years follow-up in patients treated with lowwer energy thermotherapy (Prostasoft version 2.0). J. Urol. 1996; 156: 1959-1963.
K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the international prostate symptom score. Urology 1996; 48: 393-397.
E. te Slaa, J.J. Mooibroek, Th.M. de Reijke, H.F.M. Karthaus, J-W. van Capelle, N. Tjon Pian Gi, J.J.M.C.H. de la Rosette. Laser treatment of the prostate using the urolase fiber: the dutch experience. J.Urol. 1996; 156: 420-425.
K. Ezz El Din, L.A.L.M. Kiemeney, M.J.A.M. de Wildt, P.F.W.M. Rosier, F.M.J. Debruyne, J.J.M.C.H. de la Rosette.The correlation between bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS) as measured by the international prostate symptom score (IPSS). J.Urol. 1996; 156: 1020-1025.
K. Ezz El Din, W.F.R.M. Koch, M.J.A.M. de Wildt, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Eur.Urol 1996; 30: 409-413.
W.P.J. Witjes, M.J.A.M. de Wildt, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. J. Urol.1996; 156: 1026-1034.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Computerised interpretation of ultrasonographic prostate images in the early diagnosis of prostate cancer - the AUDEX system. Oncology in practice1996; 2/96: 11-13.
R.G. Aarnink, A.L. Huynen, R.J.B. Giesen, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Automated prostate volume determination with ultrasonographic imaging. J Urol 1996; 155: 1038.
W.P.J. Witjes, P.F.W.M. Rosier, M.J.A.M. de Wildt, M.P. van Iersel, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia. J Urol 1996; 155: 1317.
R.G. Aarnink, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Formula derived prostate volume determination. Eur Urol 1996; 29(4): 399.
G.J. Jager, J.O. Barentz, E.T. Ruijter, J.J.M.C.H. de la Rosette, G.O.N. Oosterhof. Primary staging of prostate cancer. Eur Radiol 1996; 6(2): 134-139.
J.L. Donovan, P. Abrams, T.J. Peters, H.E. Kay, J. Reynard, C. Chapple, J.J.M.C.H. de la Rosette, A. Kondo, ICS ”BPH” Study group. The ICS - ”BPH” study: The psychometric validity and reliability of ICSmale questionnaire. Br.J.Urol 1996; 77: 554-562.
1997:
F.C.H. d’Ancona, E.A.E. Francisca, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy in the treatment of patients with lower urinary tract symptoms. J Endo Urol 1997; 11(4): 285-289.
W.P.J. Witjes, J.J.M.C.H. de la Rosette, J.L. Donovan, T.J. Peters, P. Abrams, H.E. Kay, K. Hofner, A.C. Kinn, S. Walter, ICS - ”BPH” study group. The ICS - ”BPH” study: International differences in lower urinary tract symptoms and related bother. J Urol 1997; 157: 1295-1300.
J.J.M.C.H. de la Rosette, H.P. Beerlage, F.M.J. Debruyne. Role of Temporary stents in alternative treatment of benign prostatic hyperplasia. J Endo Urol 1997; 11(6): 467-472.
J.L. Donovan, H.E. Kay, T.J. Peters, P. Abrams, J. Coast, A. Matos-Ferreira, L. Rentzhog, J.L.H.R. Bosch, J. Nordling, J.B. Gajewski, G. Barbalias, E. Schick, M. Mendes Silva, I. Nissenkorn, J.J.M.C.H. de la Rosette. Using the ICSQol to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-BPH study. Br. J. Urol. 1997; 80: 712-721.
T.J. Peters, J.L. Donovan, H.E. Kay, P. Abrams, J.J.M.C.H. de la Rosette, D. Porru, J.W. Thuroff and the international continence society “BPH” study group. The international continence society “benign Prostatic Hyperplasia” study: the bothersomeness of urinary symptoms. J. Urol 1997; 157: 885-889.
G. Jager, E. Ruijter, J.J.M.C.H. de la Rosette, C. Van de Kaa. Amyloidosis of the Seminal Vesicles Simulating Tumor Invasion of Prostatic Carcinoma on Endorectal MR Images. Eur Radiol 1997; 7(4): 552-454.
G. Jager, E. Ruijter, C. van de Kaa, J.J.M.C.H. de la Rosette, G. Oosterhof, J. Thornbury, J. Ruijs, J. Barentsz. Dynamic Turbo-FLASH Subtraction Technique for Contrast-enhanced MR images of the Prostate: Correlation with Histopathology. Genitourinary radiology 1997; 203: 645-652.
A. Heerschap, G. Jager, M. van der Graaf, J. Barentsz, J.J.M.C.H. de la Rosette, G. Oosterhof, E. Ruijter, J. Ruijs. In-vivo Proton MR Spectroscopy Reveals Altered Metabolic Content in Malignant Prostate Tissue. Anticancer Res1997; 17: 1455-1460.
P. Abrams, J. Donovan, J.J.M.C.H. de la Rosette, W. Schäfer and the ICS-’BPH’ study group. The international continence society “BPH” study: background, aims and methodology. Neurourol and Urodynam 1997; 16(2): 79-92.
E. te Slaa, E.A.E. Francisca, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Quality of life assessment in patients following laser prostatectomy. Br. J Urol 1997; 80: 211-216.
J.J.M.C.H. de la Rosette, F.C.H. d’Ancona, F.M.J. Debruyne. Current status of thermotherapy treatment of the prostate. J Urol 1997; 157: 430-438.
F.C.H. d’Ancona, E.A.E. Francisca, W.P.J. Witjes, L. Welling, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy thermotherapy (TUMT) versus transurethral resection (TURP) in the treatment of benign prostatic hyperplasia (BPH): results of a prospective randomized study with a 1-year follow-up. J Urol 1997; 158: 120-125.
K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Making the diagnosis of benign prostatic hyperplasia (BPH): a critical review. Eur Urol 1997; 31: 257-262.
R. Aarnink and J.J.M.C.H. de la Rosette. A preprocessing algorith for edge detection with multiple scale of resolution. European Journal of Ultrasound 1997; 5: 113-126.
W.P.J. Witjes, P.F.W.M. Rosier, C.T.M. Caris, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis. Urology 1997; 49: 197-206.
W.P.J. Witjes, R.G. Aarnink, K. Ezz-El-Din, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with symptomatic benign prostatic hyperplasia. Br. J Urol 1997; 80: 84-90.
E.A.E. Francisca, F.C.H. d’Ancona, J.C.M. Hendriks, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized TUMT versus SHAM study. J Urol 1997; 158: 1839-1844.
J.J.M.C.H. de la Rosette, R. Muschter, M.A. Lopez, D. Gillatt. Interstitial laser coagulation (ILC) in the treatment of benign prostatic hyperplasia (BPH) using a diode laser system with temperature feedback. Br.J.Urol 1997; 80: 433-438.
Bierkens, A. Hendrikx, K. Ezz El Din, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with proven sterile urine prior to treatment. Eur. Urol.1997; 31: 30-35.
Y. Xue, F. Smedts, R. Umbas, T.W. Aalders, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Changes in keratin expression during the development of benign prostatic hyperplasia (BPH). Eur Urol 1997; 32: 332-338.
Yong Xue, Albert Verhofstad, Wil Lange, Frank Smedts, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette, Jack Schalken. Prostatic Neuroendocrine Cells Have a Unique Keratin Expression Pattern and Do Not Express Bcl-2 --- cel kinetic features of neuroendocrine cells in human prostate. Am J Pathol 1997; 151 (6): 1759-1765.
Wim P.J. Witjes, H. Wijkstra, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Quantitative assessment of uroflow: is there a circadian rhythm? Urology 1997; 50: 221-228.
Wim P.J. Witjes, Andrew robertson, Peter F.W.M. Rosier, David E. Neal, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction. Urology 1997; 50: 55-61.
R.G. Aarnink, J.J.M.C.H. de la Rosette, Wouter F.J. Feitz, Frans M.J. Debruyne, H. Wijkstra. A preprocessing algorithm for edge detection with multiple scales of resolution. European Journal of Ultrasound 1997; 5:113-126.
1998:
J.J.M.C.H. de la Rosette, M. Blute, F. Degrandchamps. Transurethral thermotherapy using the Prostatron device. World J Urol 1998; 16(2): 89-96.
E.A.E. Francisca, M. Blute, J.J.M.C.H. de la Rosette. Quality of life in TUMT. World J. Urol 1998; 16(2):148-153.
H.P. Beerlage, Th. De Reijke, J.J.M.C.H. de la Rosette. Considerations regarding prostate biopsies. Eur Urol 1998; 34: 303-312.
H.P. Beerlage, E.A.E. Francisca, F.C.H. d’Ancona, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Urolase versus ultraline fibers in laser prostatectomy; 3 year follow up of a prospective randomized study. J Endo Urol 1998; 12 (nr 6), 575-580.
Frank C.H. d’Ancona, Elmer A.E. Francisca, Wim P.J. Witjes, L. Welling, Frans M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral resection of the prostate (TURP) versus high energy thermotherapy (HE-TUMT) of the prostate in patients with benign prostatic hyperplasia (BPH): long-term results. Br.J Urol 1998; 81(2): 59-264.
F.C.H. d’Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The predictive value of baseline variables in the treatment of benign prostatic hyperplasia using high energy transurethral microwave thermotherapy. Br. J Urol 1998; 82: 808-813.
J.J.M.C.H. de la Rosette, W.P.J. Witjes, W. Schafer, P. Abrams, J.L. Donovan, T.J. Peters, R.J. Millard, C Frimodt-Moller, P. Kalomiris and the ICS-BPH study group. The relationship between lower urinary tract symptoms and bladder outlet obstruction: Results from the ICS-BPH study. Neur Urol 1998;17: 99-108.
Y. Xue, J. Lie, M.A.H.E. Latijnhouwers, F. Smedts, R. Umbas, T.W. Aalders, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Expression of periglandular tenascin-C and basement membrane laminin in normal prostate, benign prostatic hyperplasia and prostate carcinoma. Br. J Urol 1998; 81: 844-851.
Y. Xue, F. Smedts, A. Verhofstad, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Cell kinetics of prostate exocrine and neuroendocrine epithelium and their differential interrelationships: new perspectives. Prostate 1998; 8: 62-73.
G.B.J.M. Keijzers, E.A.E. Francisca, F.C.H. d’Ancona, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term Results of Lower Energy TUMT (Prostasoft 2.0). J Urol 1998; 159: 1966-1973.
E. te Slaa, C.F.P. van Swol, T.A. Boon, R.M. Verdaasdonk, W.H. Doesburg, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The influence of the decay of laser fibers during laser prostatectomy on the clinical results. J Endourol 1998; 12(3): 291-295.
J. Van Drongelen, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The impact of urometabolic evaluation on the prevention of urolithiasis: a retrospective study. Urology 1998; 52(3), 384-391.
R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, H. Wijkstra. Transrectal Ultrasound of the prostate: innovations and future applications, J Urol. 1998,159: 1568-1579.
Y.Xue, F. Smedts, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Identification of intermediate cell types by keratin expression in the developing human prostate. The Prostate 1998; 34(4): 292-301.
Y. Xue, W. Lange, F. Smedts, F. Debruyne, J.J.M.C.H. de la Rosette, J Schalken, A. Verhofstad. A novel immunoenzymatic technique to demonstrate multiple antigens in cells based on selective destaining of reaction products and its application in characterizing the immunophenotype of neuroendocrine cells in the human prostate. Applied immunihistochemistry 1998; 6(2): 69-76.
A. Tubaro, J.J.M.C.H. de la Rosette, K. Hofner, A. Trucchi, and S.St.C. Carter. Correlation amongst objective and subjective parameters of bladder outlet obstruction in the clinical response to microwave thermotherapy. Urodinamica , 1998; 8: 200-210.
J.M. Reynard, Q Yang, J.L. Donovan, T.J. Peters, W. Schafer, J.J.M.C.H. de la Rosette, N.F. Dabhoiwala, D Osawa, A. Tong Long Lim, P. Abrams. The ICS-‘BPH’ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br. J Urol 1998; 82: 619-623.
K. Hofner, A Tubaro, J.J.M.C.H. de la Rosette, S.St.C. Carter. Analysis of Outcome After Thermotherapy Using Different Classifications of Bladder Outlet Obstruction. Neurourol and Urodyn 1998; 17: 109-120.
J. Donovan, S. Brookes, P. Abrams, J.J.M.C.H. de la Rosette. Are symptoms of incontinence in men relieved by treatment for bladder outlet obstruction? data from the ICS - ‘BPH’ study. Neurourol urodyn 1998; 17: 363-365.
R.G. Aarnink, S.D. Pathak, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, Y. Kim, H. Wijkstra. Edge detection in prostatic ultrasound images using integrated edge maps. Ultrasonics 1998; 36: 635-642.
A.F. Bierkens, A.J.M. Hendrikx, J.J.M.C.H. de la Rosette, G.N.M. Stultiens, H.P. Beerlage, A.J. Arends, F.M.J. Debruyne. Treatment of mid-and lower ureteric calculi: extracorporeal shock-wave lithotrypsie vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness. Br. J. Urol 1998; 81: 31-35.
Y. Xue, F. Smedts, M.A.H.E. Lathouwers, E.T.H. Ruijter, T.W. Aalders, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, J.A. Schalken. Tenascin-C Expression in Prostatic Intraepithelial Neoplasia (PIN): a marker of Progression? Anticancer Research 1998; 18: 2679-2684.
W.P. Witjes, J.J.M.C.H. de la Rosette, M. Zerbib, G.C. Vignoli, C. Geffriaud, F.M.J. Debruyne, H. Wijkstra.Computerized artifact detection and correlation of uroflow curves: towards a more consistent quantitative assessment of maximum flow. Eur. Urol 1998; 33(1): 54-63.
D. Floratos, J.J.M.C.H. de la Rosette. The value of urodynamics in laser Prostatectomy. Eur Urol 1998; (37): 509-516.
1999:
H.P. Beerlage, G.J.L.H. van Leenders, G.O.N. Oosterhof, J.A. Witjes, E.T. Ruijter, C.A. van de Kaa, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High intensity focused ultrasound (HIFU) followed after on to two weeks by radical retropubic prostatecomy: results of a prospective study. Prostate 1999; 39(1): 41-46.
F.C.H. D'Ancona, A.K. van der Bij, E.A. Francisca, H. Kho, F.M.J. Debruyne, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Results of high-energy transurethral microwave thermotherapy in patients categorized according to the American Society of Anesthesiologists operative risk classification. Urology 1999; 53(2): 322-328.
F.C. d'Ancona, Y.H. Albers, L.A. Kiemeney, Y. Xue, F. Smedts, H.G. van der Poel, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate. Results of a biopsy study. Prostate 1999; 40(1): 28-36.
H.P. Beerlage, S. Thuroff, F.M.J. Debruyne, C. Chaussy, J.J.M.C.H. de la Rosette. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 1999; 54(2): 273-277.
J.T. Bousema, M.J.G. Bussemakers, K.P. van Houwelingen, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, L.A. Kiemeney. Polymorphisms in the vitamin D receptor gene and androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol 1999; (37): 234-238.
G.S. Sonke, L.A.L.M. Kiemeney, A.L.M. Verbeek, B.B.M. Kortmann, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Low Reproducibility of Maximum Urinary Flow Rate Determined by Portable Flowmetry. Neurourol and Urodyn 1999; (18): 183-191.
A. Martenson, J.J.M.C.H. de la Rosette. Interstitial Laser coagulation in the treatment of BPH using a diode laser system: Results of an evolving technology. Prostate Cancer and Prostatic Diseases 1999; (2): 148-154.
E.A.E. Francisca, G.B.J.M. Keijzers, F.C.H. d’Ancona, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Lower energy thermotherapy (TUMT 2.0) in the treatment of BPH: Long term follow up results of a multicenter international study. World J. Urol 1999; (17): 279-284.
D.L. Floratos, J.J.M.C.H. de la Rosette. Lasers in Urology. Br.J. Urol 1999; (84): 204-211.
R.G. Aarnink, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra. Contrast Angiosonography: A technology to Improve Doppler Ultrasound Examinations of the Prostate. Eur Urol 1999; (35): 9-20.
J.L. Donovan, S.T. Brookes, J.J.M.C.H. de la Rosette, T.J. Peters, D. Porru, A. Kondo, N. Dabhoiwala, R. Millard, R. Bosch, J. Nordling, A. Matos Ferreira, K. Hofner, H. Mostafid, S. Walter, I. Nissenkorn, C. Frimodt Moller, M. Mendes Silva, C. Chapple, P. Abrams. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-‘BPH’ study. BJU International 1999; (83): 243-248,.
Yong Xue, Jeroen A.W.M. van der Laak, Mieke Latijnhouwer, Henk G. Van der Poel, J.J.M.C.H. de la Rosette, Frans M.J. Debruyne, Jack A. Schalken. Transient Tenascin Enhancement is an early event after Androgen Ablation in Rat Prostate. Urol. Res 1999; 27,9-15.
E.A.E. Francisca, F.C.H. d’Ancona, E.J.H. Meuleman, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; (161) 486-490.
J.J.M.C.H. de la Rosette and A.R. Zlotta. Alternatives treatment in BPH: Future perspectives. Eur Urol 1999; 35(2), 173-176.
H.A. Bogers, J.P.M. Sedelaar, H.P. Beerlage, J.J.M.C.H. de la Rosette, F.M.J. Debruyne, H. Wijkstra, R.G. Aarnink. Contrast-enhanced 3D Power Doppler Angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54(1), 97-104.
F.C.H. d’Ancona, E.A.E. Francisca, J.C.M. Hendriks, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. How to select patients for high energy transurethral microwave thermotherapy? Urology 1999; 53(1), 111-117.
F.C.H. d’Ancona, J.J.M.C.H. de la Rosette. Future perspectives of transurethral microwave thermotherapy. Prostatic disease 1999; 3(2), 29-31.
B.B.M. Kortmann, G.S. Sonke, F.C.H. d’Ancona, D.L. Floratos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. The tolerability of urodynamic studies and flexible cystourethroscopy used in the assessment of men with lower urinary tract symptoms. BJU International 1999; (84): 449-453.
J.O. Barentsz, M.R.W. Engelbrecht, J.A.M. Witjes, J.J.M.C.H. de la Rosette, M. van der Graaf. MR Imaging of the male Pelvis. Review article. Eur Radiol 1999 (9): 1722-1736.
2000:
Y Xue, J. van der Laak, F. Smedts, C. Schoots, J. Schalken, A Verhofstadt, J.J.M.C.H. de la Rosette. Neuroendocrine cells during human prostate development: does neuroendocrine cells density remain constant during fetal as well as postnatal life? Prostate 2000; 42(2):116-123.
G.J.L.H. van Leenders, H.P. Beerlage, E.Th. Ruijter, J.J.M.C.H. de la Rosette, C.A. van de Kaa and D.J. Ruiter. Histopathologic changes associated with High Intensity Focused Ultrasound (HIFU) therapy for localized adenocarcinoma of the prostate. J. Clin Pathol 2000 (53): 391-394.
J.J.M.C.H. de la Rosette, E.A.E. Francisca, B.B.M Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, F.M.J. Debruyne. Clinical efficacy of a new 30-minutes algorithm for transurethral microwave thermotherapy (TUMT 3.5): initial results. BJU International 2000 (86): 47-51.
G.S. Sonke, T. Heskes, A.L. Verbeek, J.J.M.C.H. de la Rosette, L.A. Kiemeney. Prediction of bladder outlet obstruction in men with lower urinary tract symptoms using artificial neural networks. J Urol 2000; 163(1):300-305.
J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H van Leenders, H.P. Beerlage, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H de la Rosette. The application of three-dimensional contrast enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol, 2000 37(5): 559-568.
B.B.M. Kortmann, G.S. Sonke, H. Wijkstra, J. Nordling, E. Kallestrup, N.R. Holm, J.J.M.C.H. de la Rosette. Intra-and inter-investigator variation in the analysis of pressure-flow studies in men with lower urinary tract symptoms. Neurourol & Urodyn 2000 (19): 221-232.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow up of laser treatment for lower urinary tract symptoms of bladder outlet obstruction. Urology 2000; 163(5): 1457-1460.
D. Unal, J.P.M. Sedelaar, R.G. Aarnink, G.J.L.H. van Leenders, H. Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Three dimensional contrast enhanced power Doppler ultrasound and conventional examination methods: value of diagnostic predictors of prostate cancer. BJU International 2000 (86): 58-64.
J.J.M.C.H. de la Rosette. What we do and don’t know about benign prostatic hyperplasia. Curr Opin Urol 10:1-2, 2000.
J.J.M.C.H. de la Rosette, M.P. Laguna, G. Pace, B.B.M. Kortmann, O. Selvaggio, F.M.J. Debruyne, F.P. Selvaggi. Efficacy and Safety of the New High Energy 30-minute transurethral Microwave Thermotherapy: Results of 1 Year follow up in a multicenter study. Techniques in Urology 2000; 6(4): 271-275.
D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral Microwave Thermotherapy in the Armamentarium of Therapeutic Modalities for Benign Prostatic Hyperplasia. Techniques in Urology 2000; 6(4): 256-261.
G.S. Sonke, B.B.M. Kortmann, A.L.M. Verbeek, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Variability of Pressure Flow Studies in Men with Lower Urinary Tract Symptoms. Neurourology and Urodynamics 2000 (19): 637-656.
J.L. Donovan, T.J. Peters, P. Abrams, S.T. Brookes, J.J.M.C.H. de la Rosette, W. Schafer. Scoring the short form ICS male SF Questionnaire. J Urol 2000 (164): 1948-1955.
M.R.W. Engelbrecht, J.O. Barentsz, G.J. Jager, M van der Graaf, A. Heerschap, J.P.M. Sedelaar, R.G. Aarnink, J.J.M.C.H. de la Rosette. Prostate cancer staging using imaging. BJU International 2000(86) suppl 1: 123-134.
E.A.E. Franciscs, B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Tolerability of 3.5 versus 2.5 High Energy Transurethral Microwave Thermotherapy. Eur Urol 2000 (38): 59-63.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, B.B.M. Kortman, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. High energy transurethral microwave thermotherapy for the treatment of patients in urinary retention. J Urol 2000 (163): 1457-1460.
G.J. Jager, J.L. Severens, J.R. Thornbury, J.J.M.C.H. de la Rosette, S.H.J. Ruijs, J.O. Barentsz. Prostate Cancer Staging: Should MR Imaging be used? A decision analytic approach. Radiology 2000(215): 445-451.
E.A.E. Francisca, F.C. d’Ancona, J.C. Hendriks, L.A. Kiemeney, F.M. Debruyne, J.J.M.C.H. de la Rosette. A randomized study comparing high-energy TUMT to TURP: quality of life aspects. Eur Urol 2000; 38(5): 569-575.
M. Bolmsjo, S. Schelin, L. Wagrell, T. Larson, J.J.M.C.H. de la Rosette, A. Mattiasson. Cell-kill modelling of microwave thermotherapy for treatment of BPH. J Endourol 2000; 14(8): 627-635.
G.S. Sonke, D. Kolman, J.J.M.C.H. de la Rosette, L.H.C. Donkers, P. Boyle, A.L.M. Kiemeney. Prevalentie van lagere urinewegsymtomen bij mannen en de invloed op hun kwaliteit van leven: het Boxmeer-onderzoek. NTVG 2000 144(53): 2558-2563.
D.L. Floratos, G.S. Sonke, E.A.E. Francisca, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000 56(4): 604-609.
D.L. Floratos, G.J. Alivizatos, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. TUMT in the armamentarium of therapeutic modalities for 'BPH'. Tech urol. 2000 6(4): 256-261.
2001:
J.P.M. Sedelaar, G.J.L.H. van Leenders, C.A. Hulsbergen-van de Kaa, H.G. van der Poel, J.A.W.M. van der Laak, F.M.J. Debruyne, H. Wijkstra, J.J.M.C.H. de la Rosette. Microvessel Density: Correlation between Contrast Ultrasonography and Histology of Prostate Cancer. Eur Urol 2001; (40) 285-293.
C. Roehrborn, G. Bartsch, R. Kirby, J Andriole, P. Boyle, J.J.C.M.H. de la Rosette, P. Perrin, E. Ramsey, J. Nordling, G.de Campos Freire, S. Arap. Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative international overview. Urology 2001; (58): 642-650.
M.P. Laguna, J.J.M.C.H. de la Rosette. The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. J Urol 2001; (166-6): 2017-2022.
D.L. Floratos, J.J.M.C.H. de la Rosette. Heat treatment of the prostate: where do we stand in 2000? Current Opinion in Urology 2001; (11): 35-41.
S.P.C. Souverein, R.M.C. Herings, J.J.M.C.H. de la Rosette, A.J. Man in ‘t Veld, R.D. Farmer, H.G.M. Leufkens. Evaluating adverse cardiovascular effects of drug treatment for Benign Prostatic Hyperplasia (BPH): methodological considerations. Journal of Clinical Epidemiology 2001; (54): 518-524.
D.L. Floratos, L.A.L.M. Kiemeney, C. Rossi, B.B.M. Kortmann, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Long-term follow up of a randomized TUMT versus TURP study. J Urol 2001 (165): 1533-1538.
J.J.M.C.H. de la Rosette, R.G. Aarnink. New Developments in Ultrasonography for the Detection of Prostate cancer. J Endourol 2001(15): 93-104.
B.S. Wadie, E-H. E. Ibrahim, J.J.M.C.H. de la Rosette, M.A. Gomha, M.A. Ghoneim. The relationship between IPSS and the objective parameters in the diagnosis of BOO: Part I: when statistics fail. J Urol 2001; 165(1): 32-34.
P. Minnee, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Transurethral Microwave Thermotherapy in Benign Prostatic Hyperplasia. Current Opinion in Urology 2001.
C. Rossi, B.B.M. Kortmann, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Alpha-blockade improves symptoms suggestive of bladder outlet obstruction (BOO) but fails to relieve BOO itself. J Urol 2001; (165): 38-41.
F. Yue, E. Smedts, Th. Ruijter, F.M.J. Debruyne, J.J.M.C.H. de la Rosette, J.A. Schalken. Branching activity in the Human Prostate: a closer look at the structure of small glandular buds. Eur Urol 2001; (39-2): 222-231.
J.P.M. Sedelaar, T.E.B. Goosen, H. Wijkstra, J.J.M.C.H. de la Rosette. Reproducibility of contrast-enhanced transrectal ultrasound of the prostate. Ultrasound in Med. & Biol 2001; (27): 595-602.
J.P.M. Sedelaar, P.L.M. Vijverberg, T.M. de Reijke, J.J.M.C.H. de la Rosette, P.J.M. Kil, J.G. Braeckman, A.J.M. Hendrikx. Transrectal Ultrasound in the Diagnosis of Prostate Cancer: State of the Art and Perspectives. Eur Urol 2001; (40-3): 275-284.
J.P.M. Sedelaar, J.G.H. van Roermund, G.L.J.H. van Leenders, C.A. Hulsbergen van de Kaa, H. Wijkstra, J.J.M.C.H. de la Rosette. Three-dimensional grayscale ultrasound: evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 2001; (57): 914-920.
D.L. Floratos, J.P.M. Sedelaar, B.B.M. Kortmann, R.G. Aarnink, H.Wijkstra, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Intra-Prostatic vasculature studies: can they predict the outcome of transurethral microwave thermotherapy for the management of bladder outflow obstruction? Prostate 2001; 46(3): 200-206.
J.J.M.C.H. de la Rosette, G. Alivizatos, M.P. Laguna. A critical evaluation of transurethral hot-water balloon thermoablation: true facts and fiction. Current Urology Reports 2001;(2 ):302-305.
J.J.M.C.H. de la Rosette. Editorial. Eur Urol 2001; 40(3): 264.
J.J.M.C.H. de la Rosette, G.Alivizatos, S. Madersbacher, M. Perachino, D. Thomas, F. Desgrandchamps, M. de Wildt. EAU Guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2001; (40): 256-263.
Y. Xue, G. Sonke, C. Schoots, J. Schalken, A. Verhofstad, J.J.M.C.H. de la Rosette, F. Smedts. Proliferative activity and branching morphogenesis in the human prostate: a closer look at pre- and postnatal prostate growth. The Prostate 2001; (49): 132-139.
J.J.M.C.H. de la Rosette. Introduction. Eur Urol 2001; 40(1).
A.L. Hoffmann, J.J.M.C.H. de la Rosette, H. Wijkstra. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: status and future developments. J Endourol 2001; 14(8): 637-642.
D.L. Floratos, J.J.M.C.H. de la Rosette. The future role of microwave therapy in benign prostatic hyperplasia. Urol Integr Invest 2001; (6-3): 215-223.
2002:
M.P. Laguna, L.A. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002: 1727-1730.
G.S. Sonke, C. Robertson, A.L.M. Verbeek, W.P.J Witjes, J.J.M.C.H. de la Rosette, A method for estimating within-patient variability in maximum urinary flow rate adjusted for voided volume. Urology 2002; (59-3): 368-372.
J.J.M.C.H. de la Rosette, B.B.M. Kortman, C. Rossi, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney. Long-term risk of retreatment in patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002; (167): 1734-1739.
J. Eckersley, J.P.M. Sedelaar, M.J. Blomley, H. Wijkstra, N.M. DeSouza, D.O. Cosgrove, J.J.M.C.H. de la Rosette. Quantitative microbubble enhanced transrectal ultrasound as tool for monitoring hormonal treatment of prostate cancer. Prostate june 2002 51(4): 256-267.
J.J.M.C.H. de la Rosette, D.K.E. van der Schoot, F.M.J. Debruyne. Recent developments in guidelines on benign prostatic hyperplasia. Current Opinion in Urology 2002; (12): 3-6.
J.J.C.M.H. de la Rosette F. Smedts, C. Schoots, H. Hoek, P. Laguna. Changing patterns of keratin expression characterize functional maturation in developing human bladder. J Urol 2002; 168(2): 709-717.
W.P.J. Witjes, J.J.M.C.H. de la Rosette, A. van den Berg-Segers, D. Colongo, G. Koch, A.R. Zlotta, A. Colau, M.J.A.M. de Wildt, H. Wijkstra. Computerised assessment of maximum urinary flow: an efficient, consistent and valid approach. Eur Urol 2002 41(2): 206-213.
B. Djavan, J.C. Nickel, J.J.M.C.H. de la Rosette, P. Abrams. The Urologist view of BPH progression: Results of an international survey. Eur. Urol 2002; 41(5): 490-496.
J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna, CC. Schulman. Laparoscopic radical prostatectomy: a European virus with global potentials. Arch. Esp. Urol. 2002; 55(6): 603-609.
P.C. Soeverein, R.M.C. Herings, A.J. Man in ‘t Veld, J.J.M.C.H. de la Rosette, R.D.T. Farmer, H.G.M. Leufkens. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur. Urol. 2002; 42: 254-261.
J. Veltman, T. Goossen, M.P. Laguna, H. Wijkstra, J.J.M.C.H. de la Rosette. New technical improvements for TRUS in diagnosis of prostate cancer. Eur Urol. Supplements 1; 2002; 1(6): 8-14.
J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna, F.M.J. Debruyne. How and when to take prostate biopsies. Eur. Urol. Supplements 1; 2002; 1(6): 15-20.
J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossens, C.A. Hulsbergen-van der Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette. The value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate 2002; 53: 246-253.
2003:
P.C. Souverein, R.M.C. Herings, J.A. Erkens, J.J.M.C.H. de la Rosette, H.G.M. Leufkes, H.G.M. Leufkens. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol. 2003; 43: 528-534.
A.L. Hoffmann, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Quantification of Prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur. Urol. 2003; 181-187.
M. Emberton, G. Andriole, J.J.C.M.H. de la Rosette, B. Djavan, K. Hofner, V. Navarrete, J. Nordling, C. Roehrborn, C. Schulman, P. Teillac, A. Tubaro, C. Nickel. BPH: A progressive disease of the ageing male. Urology. 2003; 61: 267-273.
S. Gravas, M.P. Laguna, J.J.M.C.H. de la Rosette. Thermotherapy and thermoablation for BPH. Curr. Opnion Urol. 2003; 13: 45-49.
J.J.M.C.H. de la Rosette, M.P. Laguna, S.Gravas, M.J.A.M. de Wildt. Transurethral Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in patients with Benign prostatic Hyperplasia (BPH). J. Endourol 2003; 4: 245- 251
M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van der Kaa., J.J.M.C.H. de la Rosette, R. Weissleder. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003; 348(25):2491-9.
S. Gravas, M.P. Laguna, P.J. van Hest, J.J.M.C.H. de la Rosette. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in patients with benign prostatic hyperplasia: Results of a porspective, open label, single center study with 1-year follow up. J. Endourol. 2003; 17: 425-430.
T.M. de Reijke, H.P. Beerlage, A.J. Hendrikx, J.J.M.C.H. de la Rosette, C.A. Mc.Killop. Prostate cancer: the right treatment for the right patient. Amsterdam 17 -18 Januari 2001. Prostate Cancer Prostatic Dis. 2003; 6(2): 193-197.
B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette. Long-term results after extrernal beam radiation therapy for T1-T2 localixes prostate cancer. Curr. Urol. Rep. 2003; 4:240-247.
D.L. Floratos, M.P. Laguna, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J. M.C.H. de la Rosette. Transurethral Resection versus Microwave Thermotherapy of the Prostate. A Cost-Consequences Analysis. BJU 2003; 92: 713-718.
C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate volume in the management of patients with symptomatic BPH. Eur. Urol. 2003; 44: 65-700.
B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Urodynamic Effects of Alpha-Adrenoceptor Blockers: A Review of Clinical Trials. Urology 2003; 62:1-9.
T.E.B. Goossen, J.J.M.C.H. de la Rosette, C.A. Hulsbergen-van de Kaa, H. Wijkstra. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 2003. 43(2): 124-131.
M.R. Engelbrecht, H.J. Huisman, R.J.R. Laheij, G.J. Jager, G.J.L.H. van Leenders, C.A. Hulsbergen-van de Kaa, J.J.M.C.H. de la Rosette, J.G. Blickman, J.O. Barentsz. Discrimination of prostate cancer from peripheral zone and central zone gland tissue using dynamic contrast-enhanced MR imaging. Radiology. 2003. 229(1): 248-54.
J.P.M. Sedelaar, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Progress in imaging of the prostate gland. Curr Urol Rep. 2003. 4(1):1-2.
2004:
M. Marberger., R. Harkaway, J.J.M.C.H. de la Rosette. Optimising the medical management of BPH. Eur. Urol. 2004; 45: 411-419.
C. Huidobro, M. Bolmsjö, T. Larson, J.J.M.C.H. de la Rosette, L. Wagrell, S. Schelin, T. Gorecki, A. Mattiasson. Evaluation of Prostalund coretherm microwave theromotherapy with histo-pathology, MRI and temperature mapping. J.Urol. 2004; 171:672-678.
T. Horn, B.B. Kortmann, F. Smedts, J. Nordling, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Routine bladder biopties in men with bladder outlet obstruction? Urol. 2004; 63(3): 451-456.
F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, A. Verhofstad, A. van Leenders, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentz, Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)-H MR spectroscopic imaging of human prostate cancer. J. Magn Reson Imaging. 2004; 20(2): 279-287.
C. Roehrborn, J.J.M.C.H. de la Rosette, G. Andriole. The utility of serial PSA measurements for the diagnosis of prostate cancer is preserved in men treated with the dual 5α-reductase inhibitor dutasteride.
M.C. Michel, J.J.M.C.H. de la Rosette. Efficacy and safety of tamsulosin in the treatment of urological diseases. Ashley Pub. Expert opinion Pharmacother. 2004; 5:1-10.
N. Naderi, C.A. Mochtar, J.J.M.C.H. de la Rosette. Real life practice in the management op BPH. Curr. Opin Urol 2004; 14: 41-44.
P. Bhowmick, J.E. Coad, S Bhowmick, J.L. Pryor, T. Larson, J.J.M.C.H. de la Rosette, J.C. Bischof. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int. J. Hyperthermia. 2004; 20(4): 421-439.
F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, G.J. van Leenders, A. Verhofstad, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentsz, A. Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004 Aug;20(2):279-87.
S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, J.J.M.C.H. de la Rosette. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004 Nov;46(5):547-54.
M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, M. Goepel.
Does concomitant stress incontinence alter the efficacy of tolterodine in
patients with overactive bladder? J Urol. 2004 Aug;172(2):601-4.
H. Wijkstra, M.H. Wink, J.J.M.C.H. de la Rosette. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol. 2004; Oct 5.
P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M. Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7
M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence. Internist (Berl). 2004; Dec 18.
P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M.Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7.
2005:
A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Percutaneous nephrolithotomy and its legacy. Eur. Urol. 2005; 47: 22-28
M.P. Laguna, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G. Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic surgery ans training facilities in Europe: Results of a survey of the ESUT. Eur. Urol. 2005; 47: 346-351.
C.A. Mochtar, L.A.L.M. Kiemeney, M.P. Laguna, M.M. van Riemsdijk, G.S. Barnett, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with BPH initially managed with alpha1-blockers and watchful waiting. Urol. 2005; 65 (2): 300-305.
P.C. Souverein, M.M. van Riemsdijk, J.J.M.C.H. de la Rosette, P.C.E. Opdam, H.G.M. Leufkes. Treatment pf BPH and occurrence of prostatic surgery and aute urinary retention: A population-based cohort study in the Netherlands. Eur. Urol. 2005; 47:505-510.
M.M. Barendrecht, R.P. Koopmans, J.J.M.C.H. de la Rosette, M.C. Michel. Treatment of lower urinary tract symptoms suggestive of BPH: the cardiovascular system. BJU 2005; 95(4): 19-28.
B.W. Lagerveld, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Holmium: YAG laser for treatment of strictures of vesicourethral anastomosis after radial prostatectomy. J. Endourol. 2005; 4 (19): 497-501
G. Kovacs, T. Loch, J. Hammer, R Potter, J.J.M.C.H. de la Rosette, H. Berterman. GEC-ESTRO-EAU recommendations on high dose rate brachytherapy for localized prostate cancer. J. Radiother Oncol. 2005; 74(2): 137-148.
M. van Dijk, T. Skrekas, J.J.M.C.H. de la Rosette. The associotion between lower urinary tract symptoms ans sexual dysfunction: fact or fiction? Curr. Opin Urol 2005; 15:39-44.
Martin C. Michel, J.J.M.C.H. de la Rosette. Role of muscarinic receptor antagonists in urgency and nocturia. BJU 2005; 37-42 supp 1.
M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence. Internist 2005 Jan; 46(1): 75-82.
M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, T. Schneider. Comparison of symptom severity and treatment response in patients with incontinent and continent overactive bladder. European Urology 2005; 48: 110-115.
P.C. Kauer, M.P. Laguna, G. Alivizatos, A. Jocye, R.Muschter, R.Swartz, D.Tolley, J.J.M.C.H. de la Rosette. Present practice and treatment strategies in endourological stone management: results of a survey of the European society of uro-technology (ESUT). European Urology 2005; 48: 182-188.
H. Azzouz, J.J.M.C.H. de la Rosette. Radical prostatectomy in high-risk prostate cancer. Can J Urol. 2005 Jun; 12 Suppl 2: 33-7.
M.P. Laguna, M. Brenninkmeijer, J.A. Belon, R. Marrero, H. Wijkstra, J.J.M.C.H. de la Rosette, S. Isorna. Long-term functional and urodynamic results of 50 patients receiving a modified sigmoid neobladder created with a short distal segment. J Urol. 2005 Sep; 174(3): 963-7.
S. Gravas, M.P. Laguna, M. Ehrnebo, L. Wagrell, A. Mattiasson, J.J.M.C.H. de la Rosette. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy. J Urol. 2005 Sep; 174(3): 1002-6; discussion 1006.
M.P. Laguna, B. Lagerveld, L.P. Witte, I. Kümmerlin, H. Wijkstra, J.J.M.C.H. de la Rosette. Laparoscopic assisted cryoablation of small renal masses. Actas Urol Esp. 2005 Oct; 29(9): 860-8.
M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en el aparato uirnario inferior. Arch Esp Urol 2005; 58(8): 703-706.
M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en el aparato urinario superior. Arch Esp Urol 2005; 58(8): 745-752.
M.P. Laguna, B. Lagerveld, J.J.M.C.H. de la Rosette. Tacticas y trucos endourologicos en laparoscopia. Arch Esp Urol 2005; 58(8): 789-800.
M.M. van Dijk , C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. Hourglass-shaped nitinol prostatic stent in treatment of patients with lower urinary tract symptoms due to bladder outlet obstruction. Urology 2005 Oct; 66(4): 845-9.
T. Skrekas, M.P. Laguna, J.J.M.C.H. de la Rosette. Laparoscopic radical prostatectomy: a European virus. Minimally Invasive Therapy 2005; 14:2: 98-103.
2006:
C.A. Mochtar, L.A. Kiemeney, M.M. van Riemsdijk, M.P. Laguna, F.M. Debruyne, J.J.M.C.H. de la Rosette. Post-void residual urine volume is not a good predictor of the need for invasive therapy among patients with benign prostatic hyperplasia. J Urol. 2006 Jan;175(1):213-6.
M.P. Laguna, A. Arce-Alcazar, C.A. Mochtar, R.V. van Velthoven, A. Peltier, J.J.M.C.H. de la Rosette. Construct validity of the chicken model in the simulation of laparoscopic radical prostatectomy suture. J Endourol. 2006 Jan; 20(1):69-73.
M.M. van Dijk, C.A. Mochtar, H. Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. The bell-shaped nitinol prostatic stent in the treatment of lower urinary tract symptoms: experience in 108 patients. Eur Urol. 2006 Feb;49(2):353-9.
M.M. van Dijk, J.J.M.C.H de la Rosette, and M.C. Michel. Effects of alpha 1-adrenoceptor antagonists on male sexual function. Drugs 2006; 66 (3): 287-301.
M.P. Laguna, T.M. de Reijke, H. Wijkstra, J.J.M.C.H. de la Rosette. Training in laparoscopic urology. Current Opinion in Urology 2006; 16 (2): 65-70.
C.A. Mochtar, W. Laan, K.P. Van Houwelingen, B. Franke, J.J.M.C.H. de la Rosette, J.A. Schalken, L.A.L.M. Kiemeney. Polymorphisms in the alpha(1A)-adrenoceptor gene do not modify the short- and long-term efficacy of alpha(1)-adrenoceptor antagonists in the treatment of benign prostatic hyperplasia. Bju International 2006; 97 (4): 852-855.
P. Laguna, F. Smedts, J. Nordling, T. Horn, K. Bouchelouche, A. Hopman, J.J.M.C.H. de la Rosette. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. American Journal of Clinical Pathology 2006; 125 (1): 105-110.
J.J.M.C.H. de la Rosette, G. Alivizatos. Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities? Eur Urol. 2006; 50: 418-420.
M. Oelke, K. Höfner, U. Jonas, D. Ubbink, J.J.M.C.H. de la Rosette, H. Wijkstra. Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn. 2006; 25(4): 308-17.
M.C. Michel, J.J.M.C.H. de la Rosette. Alpha-Blocker Treatment of Urolithiasis. Eur Urol. 2006; Mar 50: 213-214.
J.J.M.C.H. de la Rosette, T. Skrekas, J.W. Segura. Handling and Prevention of Complications in Stone Basketing. Eur Urol. 2006; 50: 991-999.
A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Extracorporeal Shock Wave Lithotripsy 25 Years Later: Complications and their Prevention. Eur Urol. 2006; 50: 981-990.
C.A. Mochtar, L.A. Kiemeney, M.P. Laguna, F.M. Debruyne, J.J.M.C.H. de la Rosette. PSA velocity in conservatively managed BPH: Can it predict the need for BPH-related invasive therapy? Prostate. 2006 Sep 15; 66(13): 1407-12.
M.H. Wink, H. Wijkstra, J.J.M.C.H. de la Rosette, C.A. Grimbergen. Ultrasound imaging and contrast agents: a safe alternative to MRI? Minim Invasive Ther Allied Technol. 2006; 15(2):93-100.
S. Gravas, P. Laguna, M. Melekos, J.J.M.C.H. de la Rosette. Current status of minimally invasive treatment for benign prostatic obstruction. Acta Urológica 2006; 23 (1): 37-48.
K. Kijvikai, M.P. Laguna, J.J.M.C.H. de la Rosette. Control of the large renal vein in limited dissected space during laparoscopic nephrectomy: a simple and reliable method. International Journal of Urology 2006; 13: 851-853.
M.M.C. van den Heijkant, J.J.M.C.H. de la Rosette, T.M. de Reijke. Side effects of hormonal therapy in prostate cancer. Polish Journal of Urology 2006; 59(1): 5-8.
M.H. Wink, B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Cryotherapy for renal-cell cancer: diagnosis, treatment and contrast enhanced ultrasonography for follow-up. J Endourol. 2006; 20(7): 456-9.
H. Azzouz, J.J.M.C.H. de la Rosette. HIFU: local treatment of prostate cancer. EAU-EBU update series 4 2006: 62-70.
J. Rassweiler, D. Teber, J.J.M.C.H. de la Rosette, M.P. Laguna, V. Pansodoro, T. Frede. Laparoskopische beckenchirurgie. Wo stehen wir im jahr 2006? Urologe A 2006; Aug 10.
J.J.M.C.H. de la Rosette. Extracorporeal shock wave lithotripsy and the “end of stone age”. European Urology 2006; 50: 400-406.
J.J.M.C.H. de la Rosette. Optimising assessment and treatment decisions for men with BPH. European Urology 2006; 5: 710-715.
K. Kijvikai, M. van Dijk, M.P. Laguna Pes, P. Lertsithichai, H. Wijkstra, J.J.M.C.H. de la Rosette. Clinical utility of “blind placement” prostatic stent in patients with benign prostatic obstruction: a prospective study. Urology 2006; 68(5): 1025-30.
T. Skrekas, C.A. Mochtar, B.W. Lagerveld, T.M. de Reijke, R.F. van Velthoven, J.J.M.C.H. de la Rosette, M.P. Laguna. Mentor-initiated approach in laparoscopic radical prostatectomy. J. Endourol 2006; 20(10): 831-5.
M.P. Laguna Pes, N. Wondergem, M.H. Wink, H. Wijkstra, J.J.M.C.H. de la Rosette. Avances en el diagnóstico ecográfico del cancer de prostate. Arch. Esp. Urol. 2006; 59(10): 965-976.
2007:
H.C. Arentsen, J.J.M.C.H. de la Rosette, T.M. de Reijke, S. Langbein. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer. Expert rev Mol Diagn. 2007 Jan; 7(1): 11-9.
N. Wondergem, J.J.M.C.H. de la Rosette. HIFU and cryoablation – non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound? Minimally Invasive Therapy 2007; 16(1) : 22-30.
J. Rassweiler, M. Schulze, C. Stock, D. Teber, J.J.M.C.H. de la Rosette. Bipolar transurethral resection fo the prostate – technical modifications and early clinical experience. Minimally Invasive Therapy 2007; 16(1): 11-21.
M. Hatzinger, S. Langbein, J.J.M.C.H. de la Rosette, M. Sohn, P. Alken. Die Nephropexie im Wandel der Zeit Aspekte einer historischen Operationstechnik. Urologe A 2007; Jan 13.
A. Breda, SV Stepanian, J. Liao, JS. Lam, G. Guazzoni, M. Stifelman, K. Perry, A. Celia, G. Breda, P. Fornara, S. Jackman, J. Palou, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G. Schulam. Positive margins in laparoscopic partial nephrectomy in 855 cases: a multi-institutional survey from USA and Europe. Journal of Urology 2007; 178(1):47-50.
A. Skolarikos, G. Alivizatos, P. Laguna, J.J.M.C.H. de la Rosette. A review on follow-up strategies for renal cell carcinoma after nephrectomy. European Urology 2007 jun; 51(6):1490-501.
M. Oelke, K. Höfner, U. Jonas, J.J.M.C.H. de la Rosette, D.T. Ubbink, H. Wijkstra. Diagnostic accuracy of non-invasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur. Urol. 2007; 52:827-835.
J. Baard, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The use of the Acucise technique for ureteroplevic junction obstruction: a trade-off between efficacy and invasiveness? Curr Urol Rep. 2007 Mar;8(2): 134-9.
M. Wink, M.P Laguna, B.W. Lagerveld, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU int 2007 jun; 99(6):1371-5.
S. Gravas, P. Laguna, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Durability of 30-minute high-energy transurethral microwave therapy for treatment of beningn prostatic hyperplasia: a study of 213 patients with and without urinary retention. Urology 2007 may; 69(5):854-8.
B.W. Lagerveld, R.D. ter Wee, J.J.M.C.H. de la Rosette, J.A. Spaan, H. Wijkstra. Vascular fluorescence casting and imaging cryomicrotomy for computerized three-dimensional renal arterial reconstruction. BJU Int. 2007; 100(2):387-91.
P. Tsakiris, J.J.M.C.H. de la Rosette. Imaging in genitourinary cancer from the urologists’ perspective. Cancer Imaging 2007 May 28; 7:84-92.
M.H. Wink, J.J.M.C.H. de la Rosette, M.P. Laguna, B.W. Lagerveld, H. Wijkstra. Ultrasonography of renal masses using contrast pulse sequence imaging: a pilot study. J Endourol. 2007; 21(5):466-72.
A. Breda, S.V. Stepanian, J.S. Lam, J.C. Liao , I.S. Gill, J.R. Colombo, G. Guazzoni, K.T. Perry, A. Celia, G. Breda, P. Fornara, S.V. Jackman, A. Rosales, J. Palo, M. Grasso, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomro, J.J.M.C.H. De la Rosette, M.P. Laguna, and P.G. Schulam. Use of haemostatic agnets and glues during laparoscopic partial nephrectomy: a multi-institutional survey from the United States and Europe of 1347 cases. Eur. Urol. 2007; 52(3): 798-803.
M.H. Wink, J.J.M.C.H. de la Rosette, C.A. Grimbergen, H. Wijkstra. Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer. World J Urol. 2007; 25(4): 367-73.
T.M. de Reijke, J.J.M.C.H. de la Rosette, C.N. Sternberg. Treatment approacges in patients with hormone resistant prostate cancer. Polish Journal of Urology 2007; 60(2):108-114.
S.K. Williams, J.J.M.C.H. de la Rosette, J. Landman, F.X. Keeley jr. Cryoablation of small renal tumors. EAU-EBU update series 2007; 5:206-218.
K. Kijvikai, G.E. Haleblian, G.M. Preminger, J.J.M.C.H. de la Rosette. Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol. 2007:178(4): 1157-63.
I.P. Kümmerlin, J. Borrego, M.H. Wink, M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Nephron-sparing surgery and percutaneous biopsies in renal-cell carcinoma: a global impression among endourologists. J Endourol. 2007; 21(7):709-13.
C.A. Mochtar, P.C. Kauer, M.P. Laguna, J.J.M.C.H. de la Rosette. Urinary leakage after laparoscopic radical prostatectomy: a systematic review. J endourol. 2007; 21(11):1371-80.
S. Gravas, M.D. Melekos, M.P. Laguna, J.J.M.C.H. de la Rosette. Evaluation of photoselective vaporization of the prostate. Aging Health 2007;3(6):723-730.
2008:
J. van der Wijk jr., J. van der Wijk sr., T. Horn, J.R. Nyengaard, H. Wijkstra, J. Nordling, F. Smedts, J.J.M.C.H. de la Rosette. Three-dimensional stereology as a tool for evaluating bladder outlet obstruction. Scand J Urol Nephrol. 2008; 42:40-46.
P. Tsakiris, J.J.M.C.H. de la Rosette, M.C. Michel, M. Oelke. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur. Urol. 2008; 53(1):53-9.
G. Haleblian, K. Kijvikai, J.J.M.C.H. de la Rosette, G. Preminger. Ureteral stenting and urinary stone management: a systematic review. J Urol 2008; 179(2):424-30.
M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C. Michel. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn 2008;27(3):226-30.
H. Wijkstra and J.J.M.C.H. de la Rosette. Editorial comment on: comparison of contrast-enhanced color doppler imaging (CDI), computerized tomography (CT), and magnetic resonance imaging (MRI) for the detection of crossing vessels in patients with ureteropelvic junction obstruction (UPJO). Eur. Urol. 2008; 53(6):1260-1.
M. Emberton, M. Marberger, J.J.M.C.H. de la Rosette. Understanding patient and physican perceptions of benign prostatic hyperplasia in Europe: the prostate research on behaviour and education (PROBE) survey. Int J Clin Pract. 2008;62(1):18-26.
M. Trompetter, F. Smedts, J. van der Wijk, C. Schoots, H.J. de Jong, A. Hopman, J.J.M.C.H. de la Rosette. Keratin profiling in the developing human prostate. A different approach to understanding epithelial lineage. Anticancer Research 2008; 28:237-244.
M.M. Barendrecht, P. Abrams, H. Schumacher, J.J.M.C.H. de la Rosette, M.C. Michel. Do alpha(1)-adrenoceptor antagonists imrove lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn. 2008; 27(3):226-30.
I. Kümmerlin, F. ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la Rosette, M.P. Laguna. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur. Urol. 2008; 53(6):1219-27.
L.P. Witte, C.R, Chapple, J.J.M.C.H. de la Rosette, M.C. Michel. Cholinergic innervation and muscarinic receptors in the human prostate. Eur Urol. 2008:54(2): 326-34.
P. Tsakiris, S. Thüroff, J.J.M.C.H. de la Rosette, C. Chaussy. Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence. J Endourol. 2008; 22(2):221-229.
P. Beemster, S. Phoa, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU int. 2008; 101(10): 1237-42.
A. Skolarikos, J.J.M.C.H. de la Rosette. Prvention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol. 2008:18(2): 229-34.
M. Oelke, J. Baard, H. Wijkstra, J.J.M.C.H. de la Rosette, U. Jonas, K. Höfner. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostates hyperplasia. Eur Urol. 2008:54(2):419-26.
J.J.M.C.H. de la Rosette. Facing the challenges of benign prostatic hyperplasia management. Curr Opin Urol. 2008; 18(1):9-10.
J.J.M.C.H. de la Rosette, J. Rassweiler. Editorial: innovative approaches in endoscopic surgery. J Endourol. 2008 Apr; 22(4):743-4.
S. Tabatabaei, O.M. Reich, J.J.C.M.H. de la Rosette, E.J. Collins, A. Bachmann, B.B. Choi, G.H. Muir, F.G. Sancha, H.H. Woo. International multicenter experience of the greenlight HPS120W laser in patients with benign prostatic obstruction. J of Urol. Suppl. S 2008; 179(4):627.
H.H. Woo, O.M. Reich, J.J.C.M.H. de la Rosette, E.J. Collins, A. Bachmann, B. Choi, G.H. Muir, F.G. Sancha, S. Tabatabaei. International multicenter experience of the greenlight HPS120W laser in patients with benign prostatic obstruction, in urinary retention, on anticoagulants and with large prostates. J of Urol. Suppl. S 2008; 179(4):631.
J.J.M.C.H. de la Rosette, M.P. Laguna, J.J. Rassweiler, P. Conort. Training in Percutaneous Nephrolithotomy-A Critical Review. Eur Urol. 2008; 54(5):994-1003.
M.C. Michel, U. Wetterauer, M. Vogel, J.J.M.C.H. de la Rosette. Cardiovascular safety and overall tolerability of solifenacin in routine clinical use: a 12-week, open-label, post-marketing surveillance study. Drug Saf. 2008; 31(6):505-14.
S.F. Gomez, G. Muir, A. Bachmann, B. Choi, E. Collins, J.J.C.M.H. de la Rosette, O. Reich, S. Tabatabei, H. Woo. Green light HPS laser prostatectomy: recommendations on surgical technique. Eur. Urol. Supplements 2008; 7(3):332.
B. Choi, S. Tabatabaein, A. Bachmann, E. Collins, J.J.C.M.H. de la Rosette, F. Gomez Sancha, G. Muir, O. Reich, H. Woo. GreenLight HPS 120-w laser for benign prostatic hyperplasia: Comparative complications and technical recommendations. Eur. Urol. Supplements. 2008;7(4):384-392.
J.J.M.C.H. de la Rosette, E. Collins, A. Bachmann, B. Choi, G. Muir, O. Reich, F. Gomez Sancha, S. Tabatabaei, H. Woo. Historical aspect of laser therapy for benign prostatic hyperplasia. Eur. Urol. Supplements. 2008;7(4):363-369.
G. Muir, F. Gomez Sancha, A. Bachmann, B. Choi, E. Collins, J.J.C.M.H. de la Rosette, O. Reich, S. Tabatabaei, H. Woo. Techniques and training with GreenLight HPS120-W laser therapy of the prostate: position paper. Eur. Urol. Supplements 2008;7(4):370-377.
H. Woo, O. Reich, A. Bachmann, B. Choi, E. Collins, J.J.C.M.H. de la Rosette, F. Gomez Sancha, G. Muir, S. Tabatabaei. Outcome of GreenLight HPS 120-w laser therapy in specific patient populations: those in retention, on antocoagulants, and with large prostates (>=80 ml). Eur. Urol. Supplements 2008;7(4):378-383.
P. Sountoulides, J.J.M.C.H. de la Rosette. Update on photoselcetive vaporization of the prostate. Current Urology reports 2008;9:106 - 112.
H.C. Arentsen, S. Langbein, J.J.M.C.H. de la Rosette, R.C.M. Pelger, S.D. Bos, J.G. Fernandes, T.M. de Reijke. The nuclear matrix protein 22 (NMP22) bladderchek test for the detection of bladder cancer. Polish Journal of Urology 2008; 61:24-27.
J.J.M.C.H. de la Rosette, S. Gravas, J.M. Fitzpatrick. Minimally Invasive treatment of male lower urinary tract symptoms. Urologic Clinics of North America 2008:35;505-518.
H. van Poppel, B. Tombal, J.J.M.C.H. de la Rosette, B.E. Persson, J.K. Jensen, T. Kold Olesen. Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker-results from a 1-yr multicentre, randomized, phase 2 dosage-finding study in the treatment of prostate cancer. Eur. Urol. 2008;54(4):805-15.
I. Kümmerlin, F.J. ten Kate, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU int. 2008;102(8):946-51.
M. Wink, F. Frauscher, D. Cosgrove, J.Y. Chapelon, L. Palwein, H. Mitterberger, C. Harvey, O. Rouvière, J.J.M.C.H. de la Rosette, H. Wijkstra. Contrast-enhanced ultrasound and prostate cancer; a multicentre European research coordination project. Eur Urol 2008;54(5):982-93.
P.W.T. Beemster, B.W. Lagerveld, L.P.W. Witte, J.J.M.C.H. de la Rosette, M. P. Laguna, H. Wijkstra. The Performance of 17-gauge cryoprobes in vitro. Technology in cancer research & treatment 2008;7(4):321-328.
J. Rioja, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna. Advances in diagnosis and follow-up in kidney cancer. Curr. Opin. Urol. 2008;18(5):447-54.
J.J.M.C.H. de la Rosette, P. Tsakiris, M.N. Ferrandino, A.M. Elsakka, J.Rioja, G.M. Preminger. Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Urol 2008;54(6):1262-9.
J.J.M.C.H. de la Rosette. Editorial Comment: Holmium Laser Enucleation of the Prostate-Outcomes Independent of Prostate Size? J Urol 2008;180(6):2435.
J.J.M.C.H. de la Rosette. Editorial comment on: Endoscopic combined intrarenal surgery in Galdakao-modified supine Valdivia position: a new standard for percutaneous nephrolithotomy. Eur. Urol 2008;54(6):1400-1.
J.J.M.C.H. de la Rosette, J.J. Rassweiler. Bipolar TURP treatment for BPH refractory to medication: the past, present, and future reference standard. J. Endourol. 2008;22(9):2111-2.
J.J.M.C.H. de la Rosette, J.R. Zuazu, P. Tsakiris, A.M. Elsakka, J.J. Zudaire, M.P. Laguna, T.M. de Reijke. Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the clavien classification. J Urol 2008;180(6):2489-93.
A. Celia, G. Zeccolini, G. Guazzoni, V. Pansadoro, V. Disanto, F. Porpiglia, C. Milani, C. Abbou, R. Gaston, G. Janetschek, N.A. Soomroo, P. Fornara, A. Breda, P.G. Schulam, J.J.M.C.H. de la Rosette, M.P. Laguna, J. Palou, G. Breda. Laparoscopic nephron sparing surgery: a multi-institutional European survey of 592 cases. Arch Ital Urol Androl. 2008 Sep;80(3):85-91.
J. Rioja Zuazu, V. Totziaris, M.P. Laguna Pes, T.M. de Reijke, J.J.M.C.H. de la Rosette. Laser and bladder tumors. Arch Esp Urol 2008;61(9):994-1003.
2009:
J.J.M.C.H. de la Rosette. Editorial Comment on: Mid-term results demonstrate salvage High-Intensity Focused Ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol. 2009;55(3):647-648.
I.P. Kümmerlin, F. Smedts, F.J. Ten Kate, T. Horn, F. Algaba, I. Trias, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Cytological Punctures in the Diagnosis of Renal Tumours: A Study on Accuracy and Reproducibility. Eur Urol. 2009;55(1):187-198.
I.P. Kümmerlin, F.J. Ten Kate, F. Smedts, T. Horn, F. Algaba, I. Trias, J.J.M.C.H. de la Rosette, M.P. Laguna. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract. 2009;205(1):27-34.
C. Mamoulakis, M. Trompetter, J.J.C.M.H. de la Rosette. Bipolar transurethral resection of the prostate: the golden standard reclaims it leading position. Curr Opin Urol 2009;19(1):26-32.
J.J.M.C.H. de la Rosette. Tailoring treatment in benign prostatic hyperplasia management. Curr Opin Urol 2009;19(1):1-2.
L.P. Witte, W.M. Mulder, J.J.M.C.H. de la Rosette, M.C. Michel. Muscarinic receptor antagonists for overactive bladder treatment: does one fit all? Curr Opin Urol 2009;19(1):13-9.
M.C. Michel, R.F. Schäfers, J.J.M.C.H. de la Rosette. Drug interactions in urology. Urologe A. 2009;48(3):264-9.
M.P. Laguna, T.M. de Reijke, J.J.M.C.H. de la Rosette. How far will simulators be involved into training. Current Urology Reports 2009;10:97-105.
P. Tsakiris, P. Beemster, H. Wijkstra, J.J.C.M.H. de la Rosette, P. Laguna. In vivo factors influencing the freezing cycle during cryoablation of small renal masses. J Endourol. 2009;23(3):545-9.
T. Schneider, J.J.M.C.H. de la Rosette, M.C. Michel. Nocturia: a non-specific but important symptom of urological disease. Int J Urol. 2009;16(3):249-56.
P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, J.J.C.M.H. de la Rosette. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):1779-87.
M. Oelke, C. Mamoulakis, D.T. Ubbink, J.J.M.C.H. de la Rosette, H. Wijkstra. Manual versus automatic bladder wall thickness measurements: a method comparison study. World J Urol. 2009 December; 27(6): 747–753.
E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, T.M. de Reijke. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy and future applications. Eur. Urol. 2009;56(2): 287-96.
M.C. Michel, R.F. Schäfers, J.J.M.C.H. de la Rosette. Arzneimittelinteraktionen in der urologie. Urologe 2009; 48:264-269.
E. Ramos-Barcelo, J. Rioja, P. Laguna Pes, J.J.M.C.H. de la Rosette, T. de Reijke. Is age a prognostic factor for treatment outcome in renal cell cancer-a comprehensive review. Crit Rev Oncol Hematol 2009;72(1):83-9.
V. Tzortzis, S. Gravas, M.M. Melekos, J.J.M.C.H. de la Rosette. Intraurethral lubricants: a critical literature review and recommendations. J Endourol 2009;23(5):821-6.
V. Tzortzis, C. Mamoulakis, J. Rioja, S. Gravas, M.C. Michel, J.J.M.C.H. de la Rosette. Medical Expulsive Therapy for distal ureteral stones. Drugs 2009;69(6):677-692.
S. Gravas, C. Mamoulakis, J. Rioja, V. Tzortzis, T. de Reijke, H. Wijkstra, J.J.M.C.H. de la Rosette. Advances in ultrasound technology in oncologic urology. Urol Clin N Am 2009; 36:133-145.
M.P. Laguna, P. Beemster, V. Kumar, S. Wyler, C. Anderson, F.X. Keeley, A. Bachmann, J. Rioja, C. Mamoulakis, M. Marberger, J.J.M.C.H. de la Rosette. Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur. Urol. 2009;56(2):355-61.
P.W. Beemster, I. Trias, F.J.W. ten Kate, F. Algaba, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. The diagnostic yield of immediate postcryoablation biopsies of small renal masses. J Endourol 2009;23(7):1203-7.
F. Wezel, C. Mamoulakis, J. Rioja, M.S. Michel, J.J.C.M.H. de la Rosette, P. Alken. Two contemporary series of percutaneous tract dilatation for percutaneous nephrolithotomy. J Endourol 2009;23(10):1655-61.
E.C. Cauberg, J.J.M.C.H. de la Rosette, T.M. de Reijke. How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer? Curr Opin Urol 2009;19(5):504-510.
M.P. Laguna, I. Kümmerlin, J. Rioja, J.J.M.C.H. de la Rosette. Biopsy of a renal mass: where are we now? Curr Opin Urol 2009;19(5):504-10.
P. Tsakiris, P. Beemster, H. Wijkstra, J.J.C.M.H. de la Rosette, P. Laguna. In vivo factors influencing the freezing cycle during cryoablation of small renal masses. J Endourol. 2009 Mar;23(3):545-9.
Meissner A., C. Mamoulakis, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Clinical update on testicular microlithiasis. Curr Opin Urol. 2009 Nov;19(6):615-8.
M.M. van Dijk, H. Wijkstra, F.M. Debruyne FM, J.J.M.C.H. de la Rosette, M.C. Michel. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2009; 105:1141-1146.
H. Wijkstra, J.J.M.C.H. de la Rosette. Motion Corrected Cadence CPS Ultrasound for Quantifying Response to Vasoactive Drugs in a Rat Kidney Model Editorial Comment. Urology 2009;74(3): 681-682.
J.J.M.C.H. de la Rosette, M.H. Wink, C. Mamoulakis, N. Wondergem, F.J. ten Kate, K. Zwinderman, T.M. de Reijke, H. Wijkstra. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol. J Urol. 2009 Oct;182(4):1329-36.
C. Mamoulakis, D.T. Ubbink, J.J.MC.H. de la Rosette. Bipolar versus Monopolar Transurethral Resection of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. 2009;56(5):798-809.
J.J.C.M.H. de la Rosette. A platform for global endourological research. J Endourol. 2009 Oct;23(10):1551-3.
J.J.M.C.H. de La Rosette, V. Mouraviev, T.J. Polascik. Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer. Eur Urol Suppl. 2009; 8(5): 424-432.
M.C. Michel, J.J.M.C.H. de la Rosette. Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8(6):496-503.
V. Tzortzis, S. Gravas, J.J.M.C.H. de La Rosette. Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8(6): 513-522.
M.M. van Dijk, M.A. van Dijk, H.Wijkstra, M.P. Laguna, J.J.M.C.H. de la Rosette. The effect of temporary prostatic stent on sexual functioning. Central Eur J of Urol 2009;62(2):243-248.
P. Sountoulides, M.P. Laguna, J.J.M.C.H. de la Rosette. Complications follwing augmentation cystoplasty; prevention and management. Central Eur J of Urol 2009;62(2):216-221.
H. Sadri-Ardekani, S.C. Mizrak, S.K. van Daalen, C.M. Korver, H.L. Roepers-Gajadien, M. Koruji, S. Hovingh, T.M. de Reijke, J.J.M.C.H. de la Rosette, F. van der Veen, D.G. de Rooij, S. Repping, A.M. van Pelt. Propagation of Human Spermatogonial Stem Cells In Vitro. JAMA. 2009 Nov 18;302(19):2127-2134.
L.P.W. Witte, U. Peschers, M. Vogel, J.J.M.C.H. de la Rosette, M.C. Michel. Does the number of previous vaginal deliveries affect overactive bladder symptoms and their response to treatment. LUTS 2009;1:82-87.
J.J.M.C.H. de La Rosette. Editorial comment. J Endourol 2009;23(12):1949-50.
J.J.M.C.H. de La Rosette. Editorial comment Urology 2009;74(6)1357.
2010:
P. Sountoulides, M.M. van Dijk, H. Wijkstra, J.J.M.C.H. de la Rosette, M.C. Michel. Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. World J Urol. 2010 Feb;28(1):3-8.
E.C. Cauberg, M.A. Salomons, I.P. Kümmerlin, T.M. de Reijke, A.H. Zwinderman, J.J.M.C.H. de la Rosette, F.J. Kate, M.P. Laguna Pes. Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995-2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int. 2010 Apr;105(7):922-7.
J.J.C.M.H. de la Rosette, S. Gravas. Global URS study: a prospective intenational observational study on indications and perioperative outcomes. J of Endourol 2010;24(1):1-3.
J.J.C.M.H. de la Rosette, S. Gravas. Guidelines for CROES publications. J of Endourol 2010;24(2):167-169.
R. Heuer, I.S. Gill, G. Guazzoni, Z. Kirkali, M. Marberger, J.P. Richie, J.J.M.C.H. de la Rosette. A Critical Analysis of the Actual Role of Minimally Invasive Surgery and Active Surveillance for Kidney Cancer. Eur Urol. 2010 Feb;57(2):223-32
S.C. Mizrak, J.V. Chikhovskaya, H. Sadri-Ardekani, S. van Daalen, C.M. Korver, S.E. Hovingh, H.L. Roepers-Gajadien, A. Raya, K. Fluiter, T.M. de Reijke, J.J.M.C.H. de la Rosette, A.C. Knegt, J.C. Belmonte, F. van der Veen, D.G. de Rooij, S. Repping, A.M. van Pelt. Embryonic stem cell-like cells derived from adult human testis. Hum Reprod. 2010;25(1):158-67.
G. Franco-Salinas, J.J.M.C.H. de la Rosette, M.C. Michel. Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. Clin Pharmacokinet. 2010 Mar 1;49(3):177-88.
J.J.C.M.H. de la Rosette, S. Gravas. Quality and transparency in CROES research projects. J of Endourol 2010;24(3):317.319.
J. Rioja Zuazu, M. Hruza, J.J. Rassweiler, J.J.M.C.H. de la Rosette. The Clavien classification system to optimize the documentation of PCNL morbidity. Archivio Italinano di Urologia e Andrologia 2010;82(1):20-2.
B.W. Lagerveld, P. van Horssen, M.P. Pes, J.P. van den Wijngaard, G.J. Streekstra, J.J.M.C.H. de la Rosette, H. Wijkstra, J.A. Spaan. Immediate Effect of Kidney Cryoablation on Renal Arterial Structure in a Porcine Model Studied by Imaging Cryomicrotome. J Urol. 2010 Mar;183(3):1221-1226.
J.J.C.M.H. de la Rosette, S. Gravas. Data transfer agreement form for CROES research projects. J of Endourol 2010;24(4):501-504.
E.C. Cauberg, S. Kloen, M. Visser, J.J.M.C.H. de la Rosette, M. Babjuk, V. Soukup, M. Pesl, J. Duskova, T.M. de Reijke TM. Narrow Band Imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer. Urology. 2010;76(3):658-63.
S. Eggener, G. Salomon, P.T. Scardino, J.J.C.M.H. de la Rosette, T.J. Polascik, S. Brewster Focal therapy for prostate cancer: possibilities and limitations. Eur Urol. 2010 Jul;58(1):57-64.
J.J.C.M.H. de la Rosette, S. Gravas. A multi-center, randomized international study to compare the impact of narrow band imaging versus white light cystoscopy in the recurrence of bladder cancer. J Endourol. 2010 May;24(5):660-1.
P.W. Beemster, H. Wijkstra, J.J.M.C.H. de la Rosette, A.H. Zwinderman , M.P. Pes. Quality of life and perceived pain after laparoscopic-assisted renal cryoablation. J Endourol. 2010 May;24(5):713-9.
C. Mamoulakis, J.J.M.C.H. de la Rosette, D.T. Ubbink. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022). Urology. 2010 May;75(5):1235-6.
J.J.C.M.H. de la Rosette, I. Gill, T. Polascik. Focal therapy for prostate and renal cancer--are we ready for it? J Endourol. 2010 May;24(5):663.
J.J.C.M.H. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study: a prospective international observational study on indications and perioperative outcomes. J of Endourol 2010;24(6):882-883.
J.J.C.M.H. de la Rosette, H. Ahmed, J. Barentsz, T.B. Johansen, M. Brausi, M. Emberton, F. Frauscher, D. Greene, M. Harisinghani, K. Haustermans, A. Heidenreich, G. Kovacs, M. Mason, R. Montironi, V. Mouraviev, T. de Reijke, S. Taneja, S. Thuroff , B. Tombal, J. Trachtenberg, H. Wijkstra, T. Polascik. Focal therapy in prostate cancer-report from a consensus panel. J Endourol. 2010 May;24(5):775-80.
J.J.C.M.H. de la Rosette, S. Gravas. Greenlight laser for benign prostatic hyperplasia study: a prospective international observational study on indications and perioperative outcomes. J Endourol. 2010 Jun;24(6):882-3.
A. Skolarikos, M.P. Laguna, G. Alivizatos, A.R. Kural, J.J.M.C.H. de la Rosette. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010 Jun; 24 (6) : 923-30.
J.J.M.C.H. de la Rosette. Editorial comment. Urology. 2010 Jun;75(6):1458.
M. Hruza, J.R. Zuazu, A.S. Goezen, J.J.M.C.H. de la Rosette, J.J. Rassweiler. Laparoscopic and open stone surgery. Arch Ital Urol Androl. 2010 Mar;82(1):64-71.
D.E. Zilberman, M.E. Lipkin, J.J.M.C.H. de la Rosette, M.N. Ferrandino, C. Mamoulakis, M.P. Laguna, G.M. Preminger. Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol. 2010 Oct;184(4):1261-6.
R. Autorino, G.P. Haber, R.J. Stein, A. Rane, M. De Sio, M.A. White, B. Yang, J.J.M.C.H. de la Rosette, J.H. Kaouk, M.P. Laguna. Laparoscopic training in urology: critical analysis of current evidence. J Endourol. 2010 Sep;24(9):1377-90.
J.J.C.M.H. de la Rosette, S. Gravas. News from the publication office of CROES. J of Endourol 2010;24(8):1203-1205
I.P. Kümmerlin, F.J. ten Kate, H. Wijkstra, A. Zwinderman, J.J.M.C.H. de la Rosette, M.P. Laguna. A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol. 2010 Oct;24(10):1675-9.
J.J.C.M.H. de la Rosette, S. Gravas. Progress report on CROES studies. J of Endourol 2010;24(9):1373-1376.
J.J.C.M.H. de la Rosette, S. Gravas. News from CROES: time for acknowlegdment. J of Endourol 2010;24(8):1552-1555.
J.J.C.M.H. de la Rosette, S. Gravas. News from CROES: WCE 2010 and beyond. J Endourol 2010;24(11):1704-4.
E.C. Cauberg, D.M. de Bruin, D.J. Faber, T.M. de Reijke, M. Viseer, J.J.C.M.H. de la Rosette, T.G. van Leeuwen. Quantitave measurement of attenuation coefficients of bladder biopsies using optical coherence tomography for grading urothelial carcinoma of the bladder. J Biomed Opt. 2010:15(6):066013-6.
E.C.C. Cauberg, J.J.M.C.H. de la Rosette, T.M. de Reijke. Hematurie in de huisartspraktijk: een beknopt overzicht. Modern Medicine 2010;34(2):81-84.
J.J.M.C.H. de la Rosette, S. Gravas.Paul J. van Cangh: Food for thought. J Endourol 2010;24(12):1895-1897.
2011:
K. Kijvikai, J.J.M.C.H. de la Rosette. Assessment of stone composition in the management of urinary stones. Nat Rev Urol. 2011;8(2):81-5.
E.C.C. Cauberg, C. Mamoulakis, J.J.M.C.H. de la Rosette, T.M. de Reijke. Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 2011; 29(4):503-9.
J.J.C.M.H. de la Rosette, R. Davis III, D. Frankel. T. Kold Olesen. Efficacy and safety of androgen deprivation therapy after switching from monthly leuprolide to monthly degarelix in patients with prostate cancer. Int J Clin Pract 2011;65(5):559-66.
M.C. Michel, M. Oelke, M. Vogel, J.J.M.C.H. de la Rosette. Which single-item measures of overactive bladder symptom treatment correlate best with patient satisfaction? Neurourology and urodynamics 2011;30(4):510-4.
S. van Rees Vellinga, J. J.C.M.H. de la Rosette. The CROES data management system: a glimpse behind the scenes. J Endourol 2011;25(1):1-5.
K.D.M. de Bruin, E.C. Cauberg, D.J. Faber, T.G. van Leeuwen, H. Wijkstra, J.J.C.M.H. de la Rosette, M.P. Laguna. Advanced diagnostics in renal mass using optical coherence tomography: a preliminary report 2011;25(2):311-5.
J.J.C.M.H. de la Rosette, D. Assimos, M. Desai, J. Gutierrez, J. Lingeman, R. Scarpa, A. Tefekli. The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: indications, complications and outcomes in 5803 patients. J Endourol 2011;25(1):11-7.
P.W. Beemster, K. Barwari, C. Mamoulakis, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results. BJU Int. 2011;108(4):577-82.
Rioja, C. Mamoulakis, H. Sodha, J. Suwijn, P. Laguna, J.J.C.M.H. de la Rosette. A plea for centralized care for ureteroscopy results from a comparative study under different conditions within the same center. J Endourol. 2011. Mar;25(3):425-9.
T. Lopes, K. Sangam, P. Alken, B.S. Barroilhet, C. Saussine, L. Shi, J.J.C.M.H. de la Rosette; Clinical Research Office of The Endourological Society Percutaneous Nephrolithotomy Study Group. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: tract dilation comparisons in 5537 patients. J Endourol. 2011 May;25(5):755-62
S. Gravas, A. Bachmann, O. Reich, C.G. Roehrborn, P.J. Gilling, J.J.C.M.H. de La Rosette. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011 Apr;107(7):1030-43.
A. Yamaguchi, A. Skolarikos, N.P. Buchholz, G.B. Chomón, M. Grasso, P. Saba, S. Nakada, J.J.C.M.H. de la Rosette; Clinical Research Office Of The Endourological Society. Percutaneous Nephrolithotomy Study Group. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study. J Endourol. 2011 Jun;25(6):933-9.
K. Barwari, I.P. Kummerlin, F.J. Ten Kate, F. Algaba, I. Trias, H. Wijkstra, J.J.M.C.H. de la Rosette, P. Laguna. What is the added value of combined core biopsy and fine needle aspiration in the diagnostic process of renal tumours? World J Urol. 2011 May 28.
M. Desai, A. De Lisa, B. Turna, J. Rioja, H. Walfridsson, A. D'Addessi, C. Wong, J.J.M.C.H. de la Rosette On Behalf Of The Croes Pcnl Study Group. The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol. 2011 Aug;25(8):1263-8.
B.W. Lagerveld, P. van Horssen, M.P. Laguna, J.P. van den Wijngaard, M. Siebes, H. Wijkstra, J.J.M.C.H. de la Rosette, J.A. Spaan. Gradient changes in porcine renal arterial vascular anatomy and blood flow after cryoablation. J Urol. 2011 Aug;186(2):681-6.
C.H. van der Vlies, D.C. Olthof, O.M. van Delden, K.J. Ponsen, J.J.M.C.H. de la Rosette, T.M. de Reijke, J.C. Goslings. Management of blunt renal injury in a level 1 trauma centre in view of the European guidelines. Injury. 2011 Jul 8.
P.J. Osther, H. Razvi, E. Liatsikos, T. Averch, A. Crisci, J.L. Garcia, A. Mandal A, J.J.C.M.H. de la Rosette; Croes PCNL Study Group. Percutaneous nephrolithotomy among patients with renal anomalies: patient characteristics and outcomes; a subgroup analysis of the clinical research office of the endourological society global percutaneous nephrolithotomy study. J Endourol. 2011 Oct;25(10):1627-32.
K. Barwari, P.W. Beemster, M.N. Hew, H. Wijkstra, J.J.C.M.H. de la Rosette, M.P. Laguna. Are there parameters that predict a nondiagnostic biopsy outcome taken during laparoscopic-assisted cryoablation of small renal tumors? J Endourol. 2011 Sep;25(9):1463-8.
E.C.C. Cauberg, J.J.M.C.H. de la Rosette, T.M. de Reijke. Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature. Indian J Urol. 2011 Apr;27(2):245-51.
M. Smeenge, M. Mischi, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, H. Wijkstra. Novel contrast-enhanced ultrasound imaging in prostate cancer. World J Urol. 2011 Oct;29(5):581-7.
E.C. Cauberg, C.Y. Nio, J.J.M.C.H. de la Rosette, M.P. Laguna, T.M. de Reijke. Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria? J Endourol. 2011 Nov;25(11):1733-40.
M.C. Rassweiler, C. Mamoulakis, H.G. Kenngott, J. Rassweiler, J.J.C.M.H. de la Rosette, M.P. Laguna. Classification and detection of errors in minimally invasive surgery. J Endourol. 2011 Nov;25(11):1713-21.
K. Barwari, D.M. De Bruin, D.J. Faber, T.G. Van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna. New optical diagnostic tools in renal cell cancer. Minerva Urol Nefrol. 2011 Sep;63(3):213-25.
J.G. Valdivia, R.M. Scarpa, M. Duvdevani, A.J. Gross, R.B. Nadler, K. Nutahara, J.J.M.C.H. de la Rosette; Croes PCNL Study Group. Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study. J Endourol. 2011 Oct;25(10):1619-25.
K. Barwari, D.M. De Bruin, D.J. Faber, T.G. Van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna. New optical diagnostic tools in renal cell cancer. Minerva Urol Nefrol. 2011 Sep;63(3):213-25.
K. Barwari, J.J.C.M.H. de la Rosette, P. Laguna. The penetration of renal mass biopsy in daily practice: A survey among urologists. J Endourol. 2011 Dec 27.
2012:
S. Gravas, V. Tzortzis, S.I. de la Riva, P. Laguna, J.J.M.C.H. de la Rosette. Focal therapy for prostate cancer: patient selection and evaluation. Expert Rev Anticancer Ther. 2012 Jan;12(1):77-86.
C. Mamoulakis, A. Skolarikos, M. Schulze, C.M. Scoffone, J.J. Rassweiler, G. Alivizatos, R.M. Scarpa, J.J.M.C.H. de la Rosette. Results from an international multicentre double-blind randomized controlled trial on the perioperative efficacy and safety of bipolar vs monopolar transurethral resection of the prostate. BJU Int. 2012 Jan;109(2):240-248.
E.R. Cordeiro, K. Barwari, A. Anastasiadis, M. García, F. Branco, J.J.M.C.H. de la Rosette, M.P. Laguna. Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol. 2013 Jan;66(1):41-53. English, Spanish.
J. Gutierrez, A. Smith, P. Geavlete, H. Shah, A.R. Kural, M. de Sio, J.H. Amón Sesmero, A. Hoznek, J.J.M.C.H. de la Rosette; On behalf of the CROES PCNL Study Group. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. 2012 Feb 25.
M. Smeenge, J. Barentsz, D. Cosgrove, J.J.C.M.H. de la Rosette, T. de Reijke, S. Eggener, F. Frauscher, G. Kovacs, S.F. Matin, M. Mischi, P. Pinto, A. Rastinehad, O. Rouviere,G. Salomon, T. Polascik, J. Walz, H. Wijkstra, M. Marberger. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU Int. 2012 Mar 30.
D. Opondo, A. Tefekli, T. Esen, G. Labate, K. Sangam, A. De Lisa, H. Shah, J.J.C.M.H. de la Rosette; on behalf of the CROES PCNL study group. Impact of Case Volumes on the Outcomes of Percutaneous Nephrolithotomy. Eur Urol. 2012 Mar 16.
W. Xue, D. Pacik, W. Boellaard, A. Breda, M. Botoca, J. Rassweiler, B. Van Cleynenbreugel, J.J.M.C.H. de la Rosette; CROES PCNL Study Group. Management of single large nonstaghorn renal stones in the CROES PCNL global study. J Urol. 2012 Apr;187(4):1293-7.
K. Barwari, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna.Differentiation between normal renal tissue and renal tumours using functional optical coherence tomography: a phase I in vivo human study. BJU Int. 2012 May 10.
S. Guven, A. Frattini, B. Onal, M. Desai, E. Montanari, J. Kums, M. Garofalo, J.J.C.M.H. de la Rosette; on behalf of the CROES PCNL Study Group. Percutaneous nephrolithotomy in children in different age groups: data from the Clinical Research Office of the Endourological Society (CROES) Percutaneous Nephrolithotomy Global Study. BJU Int. 2012 May 11.
J.J.M.C.H. de la Rosette. The time is now--the ability is yours. Eur Urol. 2012 Jun;61(6):1194-5; discussion 1195-6.
A.C. Mues, R. Korets, J.A. Graversen, K. Badani, V. Bird, S.L. Best, J.A. Cadeddu, R. Clayman, E.M. McDougall, K. Barwari, P. Laguna, J.J.M.C.H. de la Rosette, L.R. Kavoussi, Z. Okhunov, R. Munver, S.R. Patel, S.Y. Nakada, M. Tsivian, T.J. Polascik, A. Shalhav, W.B. Shingleton, E. Johnson, J.S. Wolf Jr, J. Landman. Clinical, Pathologic and Functional Outcomes after Nephron-Sparing Surgery in Patients with a Solitary Kidney: A Multi-center Experience. J Endourol. 2012 June 5.
K. Barwari, J.J.M.C.H. de la Rosette, M.P. Laguna. The penetration of renal mass biopsy in daily practice: a survey among urologists. J Endourol. 2012 Jun;26(6):737-47.
A. Skolarikos, M.P. Laguna, J.J.M.C.H. de la Rosette. Conservative and radiological management of simple renal cysts: a comprehensive review. BJU Int. 2012 Jul;110(2):170-8.
Z. Okeke, A.D. Smith, G. Labate, A. D'Addessi, R. Venkatesh, D. Assimos, W.E. Strijbos, J.J.M.C.H. de la Rosette; CROES PCNL Study Group. Prospective comparison of outcomes of percutaneous nephrolithotomy in elderly patients versus younger patients. J Endourol. 2012 Aug;26(8):996-1001.
B. Pieters, H. Wijkstra, M. van Herk, R. Kuipers, E. Kaljouw, J.J.M.C.H. de la Rosette, Koning C. Contrast-enhanced ultrasound as support for prostate brachytherapy treatment planning. J Contemp Brachytherapy. 2012 Jun;4(2):69-74.
E.R. Cordeiro, X. Cathelineau, S. Thüroff, M. Marberger, S. Crouzet, J.J.M.C.H. de la Rosette. High-intensity focused ultrasound (HIFU) for definitive treatment of prostatecancer. BJU Int. 2012 Jun 6.
J.J.M.C.H. de la Rosette, S. van Rees Vellinga, S. Gravas. CROES global PCNL project: completing the puzzle of quality. J Endourol. 2012 Jun;26(6):581-4.
L. Cormio, G.I. Gonzalez, D. Tolley, M. Sofer, A. Muslumanoglu, H.C. Klingler, J.U. Stolzenburg, J.J.M.C.H. de la Rosette. Exit strategies following percutaneous nephrolithotomy (PCNL): a comparison of surgical outcomes in the Clinical Research Office of the Endourological Society (CROES) PCNL Global Study. World J Urol. 2012 Jul 1.
J.J.M.C.H. de la Rosette, S. van Rees Vellinga, S. Gravas. CROES global PCNL project: completing the puzzle of quality. J Endourol. 2012 Jun;26(6):581-4.
A. Tefekli, A. Tepeler, T. Akman, M. Akçay, M. Baykal, M.A. Karadağ, A.Y. Muslumanoglu, J.J.M.C.H. de la Rosette. Erratum to: The comparison of laparoscopic pyelolithotomy and percutaneous nephrolithotomy in the treatment of solitary large renal pelvic stones. Urol Res. 2012 Jul 7.
M.N. Hew, R. Zonneveld, I.P. Kümmerlin, D. Opondo, J.J.M.C.H. de la Rosette, Laguna MP. Age and gender related differences in renal cell carcinoma in a European cohort. J Urol. 2012 Jul;188(1):33-8.
A. Fuller, H. Razvi, J.D. Denstedt, L. Nott, M. Pearle, F. Cauda, D. Bolton, A. Celia, J.J.M.C.H. de la Rosette; CROES PCNL Study Group. The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome. J Urol. 2012 Jul;188(1):138-44.
M. Smeenge, J.J.M.C.H. de la Rosette, H. Wijkstra. Current status of transrectal ultrasound techniques in prostate cancer. Curr Opin Urol. 2012 Jul;22(4):297-302.
L. Cormio, A. Perrone, G. Di Fino, N. Ruocco, M. De Siati, J.J.M.C.H. de la Rosette, G. Carrieri. TachoSil(®) sealed tubeless percutaneous nephrolithotomy to reduce urine leakage and bleeding: outcome of a randomized controlled study. J Urol. 2012 Jul;188(1):145-50.
K. Sairam, C.M. Scoffone, P. Alken, B. Turna, H.S. Sodha, J. Rioja, J.S. Wolf Jr, J.J.M.C.H. de la Rosette; on behalf of the CROES PCNL Study Group. Percutaneous Nephrolithotomy and Chronic Kidney Disease: Results from the CROES PCNL Global Study. J Urol.2012 Aug 15.
J.J.M.C.H. de la Rosette, D. Opondo, F.P. Daels, G. Giusti, A. Serrano, S.V. Kandasami, J.S. Wolf Jr, M. Grabe, S. Gravas; on behalf of the CROES PCNL Study Group. Categorisation of Complications and Validation of the Clavien Score for Percutaneous Nephrolithotomy. Eur Urol. 2012 Aug;62(2):246-255.
J.J.M.C.H. de la Rosette, D. Opondo. Reply from Authors re: Jens J. Rassweiler, Marie-Claire Rassweiler, Maurice-Stephan Michel. Classification of Complications:Is the Clavien-Dindo Classification the Gold Standard? Eur Urol 2012;62:256-8:The Boundary of Surgical Errors and Complications. Eur Urol. 2012 Aug; 62(2):259-60.
M.P. Laguna, P.J. Zondervan, J.J.M.C.H. de la Rosette. Focal therapy in the management of small renal masses. Curr Opin Urol. 2012 Sep;22(5):372-8.
A. Anastasiadis, E. Cordeiro, M.T. Bus, G. Alivizatos, J.J.M.C.H. de la Rosette, Th.M. de Reijke. Follow-up procedures for non-muscle-invasive bladder cancer: an update. Expert Rev Anticancer Ther. 2012 Sep;12(9):1229-41.
S. Gravas, E. Montanari, P. Geavlete, B. Onal, A. Skolarikos, M. Pearle, Y.H. Sun, J.J.M.C.H. de la Rosette. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol. 2012 Sep;188(3):843-7.
C.A. Teitsma, J.J.M.C.H. de la Rosette, M.C. Michel. Are polymorphisms of the β(3) -adrenoceptor gene associated with an altered bladder function? Neurourol Urodyn. 2012 Sep 12.
J.J.M.C.H. de la Rosette, S. van Rees Vellinga, S. Gravas. A report from the publication office. J Endourol. 2012 Oct;26(10):1254-6.
L. Cormio, G. Preminger, C. Saussine, N.P. Buchholz, X. Zhang, H. Walfridsson, A.J. Gross, J.J.M.C.H. de la Rosette. Nephrostomy in percutaneous nephrolithotomy (PCNL): does nephrostomy tube size matter? Results from The Global PCNL Study from The Clinical Research Office Endourology Society. World J Urol. 2012 Oct 17.
P.J. Zondervan, A.S. Gozen, D. Opondo, J.J. Rassweiler, J.J.M.C.H. de la Rosette, M.P. Laguna. Partial nephrectomy: is there an advantage of the self-retaining barbed suture in the perioperative period? A matched case-control comparison. World J Urol. 2012 Oct;30(5):659-64.
P. Gontero, S. Joniau, M. Oderda, M. Ruutu, H. Van Poppel, M.P. Laguna, J.J.M.C.H. de la Rosette, Z. Kirkali. Active surveillance for small renal tumors: Have clinical concerns been addressed so far? Int J Urol. 2012 Nov 6.
G. Russo, M. Mischi, W. Scheepens, J.J.M.C.H. de la Rosette, HWijkstra H. Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int. 2012 Dec;110(11 Pt C):E794-808.
E. Montanari, J.J.M.C.H. de la Rosette, F. Longo, A. Del Nero, P. Laguna. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer. Arch Ital Urol Androl. 2012 Dec;84(4):179-83.
M.T. Bus, E.R. Cordeiro, A. Anastasiadis, N.M. Klioueva, J.J.M.C.H. de la Rosette, Th.M. de Reijke. Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review. Expert Rev Anticancer Ther. 2012 Dec;12(12):1529-36.
2013:
K. Barwari, H. Wijkstra, O.M. van Delden, J.J.M.C.H. de la Rosette, Laguna MP. Contrast-Enhanced Ultrasound for the Evaluation of the Cryolesion After Laparoscopic Renal Cryoablation: An Initial Report. J Endourol. 2013 Jan 15.
P. Abrams, C. Chapple, S. Khoury, C. Roehrborn, J.J.M.C.H. de la Rosette; International Consultation on New Developments in Prostate Cancer and Prostate Diseases. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013 Jan;189(1 Suppl):S93-S101.
A.D. Seftel, J.J.M.C.H. de la Rosette, J. Birt, V. Porter, V. Zarotsky, L. Viktrup. Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data. Int J Clin Pract. 2013 Jan;67(1):32-45.
S. Andonian, C.M. Scoffone, M.K. Louie, A.J. Gross, M. Grabe, F.P. Daels, H.N. Shah HN, J.J.C.M.H. de la Rosette; CROES PCNL Study Group. Does imaging modality used for percutaneous renal access make a difference? A matched case analysis. J Endourol. 2013 Jan;27(1):24-8.
E.R. Cordeiro, K. Barwari, A. Anastasiadis, M. García, F. Branco, J.J.M.C.H. de la Rosette, M.P. Laguna. Laparoscopic cryotherapy for small renal masses: Current State. Arch Esp Urol. 2013 Jan;66(1):41-53.
S. Naito, S. van Rees Vellinga, J.J.M.C.H. de la Rosette. Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. J Endourol. 2013 Jan;27(1):1-3.
J.J.M.C.H. de la Rosette, D. Opondo. Reply to Chandra Shekhar Biyani, Andy Myatt,Victor Palit, Neil Burgess and Adrian D. Joyce's letter to the editor re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of complications and validation of the clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-55. Eur Urol. 2013 Feb;63(2):e25-6.
A. Tefekli, T. Esen, P.J. Olbert, D. Tolley, R.B. Nadler, Y.H. Sun, M. Duvdevani, J.J.M.C.H. de la Rosette; CROES PCNL Study Group. Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study. J Urol. 2013 Feb;189(2):568-73.
L. Cormio, O. Selvaggio, G. Di Fino, P. Massenio, P. Annese, J.J.M.C.H. de la Rosette, G. Carrieri. Transurethral distal ureter balloon occlusion and detachment: a simple means of managing the distal ureter during radical nephroureterectomy. J Endourol. 2013 Feb;27(2):139-42.
A. Tefekli, E. Cordeiro, J.J.M.C.H. de la Rosette. An update on percutaneous nephrolithotomy: lessons learned from the CROES PCNL Global Study. Minerva Med. 2013 Feb;104(1):1-21.
D. Opondo, J.J.M.C.H. de la Rosette. CROES survey-based studies: the role of expert opinion in endourologic research. J Endourol. 2013 Feb;27(2):118-9.
M.N. Hew, P. Zondervan, S. Guven, J.J.M.C.H. de la Rosette, P. Laguna. Prognostic models and factors for patients with renal cell carcinoma; a survey on their use amongst urologists. J Endourol. 2013 Feb 4.
C.S. Biyani, A. Myatt, V. Palit, N. Burgess, A.D. Joyce. Re: Jean J.M.C.H. de la Rosette, Dedan Opondo, Francisco P.J. Daels, et al., on behalf of the CROES PCNL Study Group. Categorisation of complications and validation of the clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-55. Eur Urol. 2013 Feb;63(2):e23-4.
W. van den Bos, B.G. Muller, J.J.M.C.H. de la Rosette. A randomized controlled trial on focal therapy for localized prostate carcinoma: hemiablation versus complete
ablation with irreversible electroporation. J Endourol. 2013 Mar;27(3):262-4.
S. Gravas, J.J.M.C.H. de la Rosette. Investigational therapies targeted to the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2013 Mar;22(3):357-68.
S. Houtzager, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. Evaluation of renal masses with contrast-enhanced ultrasound. Curr Urol Rep. 2013 Apr;14(2):116-23.
C. Mamoulakis, M. Schulze, A. Skolarikos, G. Alivizatos, R.M. Scarpa, J.J. Rassweiler, J.J.M.C.H. de la Rosette, C.M. Scoffone. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Urol. 2013 Apr;63(4):667-76.
Skolarikos, G. Alivizatos, R.M. Scarpa, J.J. Rassweiler, J.J.M.C.H. de la Rosette, C.M. Scoffone. Reply from Authors re: Alexander Bachmann, Gordon H. Muir, Stephen F. Wyler, Malte Rieken. Surgical Benign Prostatic Hyperplasia Trials: The Future is Now! Eur Urol 2013;63:677-9: Best Available Evidence in 2012 on Bipolar Versus Monopolar Transurethral Resection of the Prostate for Benign Prostatic Obstruction: It's About Time to Decide! Eur Urol. 2013 Apr;63(4):679-80.
C. Mamoulakis, D.T. Ubbink, F. Sofras, J.M. N'Dow, J.J.M.C.H. de la Rosette. Re: Huang et al.: Bipolar transurethral resection of the prostate causes deeper coagulation depth and less bleeding than monopolar transurethral prostatectomy (Urology 2012; 80:1116-1120). Urology. 2013 May;81(5):1113-5.
B. Pieters, H. Wijkstra, M. van Herk, R. Kuipers, E. Kaljouw, J.J.M.C.H. de la Rosette, Koning C. Contrast-enhanced ultrasound as support for prostate brachytherapy treatment planning. J Contemp Brachytherapy. 2012 Jun;4(2):69-74.
F. Frauscher, J.J.M.C.H. de la Rosette. Editorial Comment. Urology. 2013 Jun 20.
E. Cordeiro, A. Anastasiadis, M.T. Bus, G. Alivizatos, J.J.M.C.H. de la Rosette, T.M. de Reijke. Is photodynamic diagnosis ready for introduction in urological clinical practice? Expert Rev Anticancer Ther. 2013 Jun;13(6):669-80.
M. Oelke, A. Bachmann, A. Descazeaud, M. Emberton, S. Gravas, M. Michel, J. N'dow, J. Nordling, J.J.M.C.H. de la Rosette. EAU Guidelines on the Treatment and Follow-up of Non-Neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction. Eur Urol. 2013 Jul;64(1):118-40.
M. Kuenen, I. Herold, H. Korsten, J.J.M.C.H. de la Rosette, H. Wijkstra, M. Mischi. Maximum-likelihood estimation for indicator dilution analysis. IEEE Trans Biomed Eng. 2013 Nov 11.
B. Muller, W. van den Bos, M. Brausi, F. Cornud, P. Gontero, A. Kirkham, P. Pinto, T.J. Polascik, A.R. Rastinehad, Th.M. de Reijke, J.J.M.C.H. de la Rosette, O. Ukimura, A. Villers, J. Walz, H. Wijkstra, M. Marberger. The Role of Multiparametric Magnetic Resonance Imaging in Focal Therapy for Prostate Cancer: A Delphi Consensus Project. BJU Int. 2013 Nov 1.
M.N. Hew, P.J. Zondervan, S. Guven, J.J.M.C.H. de la Rosette, M.P. Laguna. Prognostic models and factors for patients with renal-cell carcinoma: a survey on their use among urologists. J Endourol. 2013 Jun;27(6):790-9.
C. Mamoulakis, A. Skolarikos, M. Schulze, C.M. Scoffone, J.J. Rassweiler, G. Alivizatos, R.M. Scarpa, J.J.M.C.H. de la Rosette. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. BJU Int. 2013 Jul;112(1):109-20.
D.I. Chu, M.E. Lipkin, A.J. Wang, M.N. Ferrandino, G.M. Preminger, K. Kijvikai, N.P. Gupta, M.D. Melekos, J.J.M.C.H. de la Rosette; CROES Global PCNL study group. Lithotrites and postoperative fever: does lithotrite type matter? Results from the Clinical
Research Office of the Endourological Society Percutaneous Nephrolithotomy Global
Study. Urol Int. 2013;91(3):340-4.
M.N. Hew, D. Opondo, E.R. Cordeiro, K.A. van Donselaar-van der Pant, F.J. Bemelman, M.M. Idu, J.J.M.C.H. de la Rosette, M,P. Laguna. The 1-year decline in estimated glomerular filtration rate (eGFR) after radical nephrectomy in patients with renal masses and matched living kidney donors is the same. BJU Int. 2013 Jul 2.
A. Smith, T.D. Averch, K. Shahrour, D. Opondo, F.P. Daels, G. Labate, B. Turna, J.J.M.C.H. de la Rosette ; CROES PCNL Study Group. A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy. J Urol. 2013 Jul;190(1):149-56.
G.M. Kamphuis, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Improvements in endoscopic urothelial tumor visualization. J Endourol. 2013 Nov;27(11):1314-5.
J.J.M.C.H de la Rosette. No one of us is as smart as all of us. BJU Int. 2013
Nov;112(7):881-2.
B.G. Muller, J.J. Fütterer, R.T. Gupta, A. Katz, A. Kirkham, J. Kurhanewicz, J.W. Moul,
P.A. Pinto, A.R. Rastinehad, C. Robertson, J.J.M.C.H. de la Rosette, R. Sanchez-Salas, J.S. Jones, O. Ukimura, S. Verma, H. Wijkstra, M. Marberger. The Role of Magnetic Resonance Imaging in Focal Therapy for Prostate Cancer: Recommendations from a Consensus Panel. BJU Int. 2013 Nov 12.
E.R. Cordeiro, D.E. Geijsen, P.J. Zum Vörde Sive Vörding, G. Schooneveldt, J. Sijbrands, M.C. Hulshof, J.J.M.C.H. de la Rosette, Th.M. de Reijke, H. Crezee. Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study. J Endourol. 2013 Dec;27(12):1504-9.
M.P. Kuenen, T.A. Saidov, H. Wijkstra, J.J.M.C.H. de la Rosette, M, Mischi. Spatiotemporal correlation of ultrasound contrast agent dilution curves for angiogenesis
Localization by dispersion imaging. IEEE Trans Ultrason Ferroelectr Freq Control.
2013 Dec ;60(12):2665-9.
2014:
W. van den Bos, B.G. Muller, H. Ahmed, C.H. Bangma, E. Barret, S. Crouzet, S.E. Eggener, I.S. Gill, S. Joniau, G. Kovacs, S. Pahernik, J.J.M.C.H. de la Rosette, O. Rouvière, G. Salomon, J.F. Ward, P.T. Scardino. Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design. Eur Urol. 2014 Jan 13.
E. Perez Castro, P.J. Osther, V. Jinga, H. Razvi, K.G. Stravodimos, K. Parikh, A.R. Kural, J.J.M.C.H. de la Rosette; on behalf of the CROES Ureteroscopy Global Study Group.
Differences in Ureteroscopic Stone Treatment and Outcomes for Distal, Mid-,
Proximal, or Multiple Ureteral Locations : The Clinical Research Office of the
Endourological Society Ureteroscopy Global Study. Eur Urol. 2014 Jan 23.
J.J.M.C.H. de la Rosette. Lower urinary tract symptoms in the elderly male: choosing
wisely. J Urol. 2014 Feb;191(2):289-90.
L.P. Witte, C.A. Teitsma, J.J.M.C.H. de la Rosette, M.C. Michel. Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications? Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):207-14.
J.J.M.C.H. de la Rosette. Lower urinary tract symptoms in the elderly male: choosing wisely. J Urol. 2014 Feb;191(2):289-90.
J.J.M.C.H de la Rosette, J. Denstedt, P. Geavlete, F. Keeley, T. Matsuda, M. Pearle, G. Preminger, O. Traxer ; CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014 Feb;28(2):131-9.
W. Artibani, J.J.M.C.H de la Rosette, J. Denstedt, P. Geavlete, F. Keeley, T. Matsuda, M. Pearle, G. Preminger, O. Traxer; CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014 Feb ;28(2):131-9.
J. Baard, G.M. Kamphuis, M. Westendarp, J.J.M.C.H. de la Rosette. How well tolerated is supine percutaneous nephrolithotomy? Curr Opin Urol. 2014 Mar;24(2):184-8.
P.G. Wagstaff, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna. The role of imaging in the active surveillance of small renal masses. Curr Urol Rep. 2014 Mar ;15(3):386.
W. van den Bos, B.G. Muller, B. Ehdaie, P. Scardino, J.J.M.C.H. de la Rosette. What is still needed to make focal therapy an accepted segment of standard therapy? Curr Opin Urol. 2014 May;24(3):247-55.
L. Cormio, J.J.M.C.H. de la Rosette. The upper tract-transitional-cell carcinoma global study: a prospective observational study exploring indications, treatment modalities, and outcomes worldwide. J Endourol. 2014 May;28(5):500-1.
A. Fuller A, H. Razvi, J.D. Denstedt, L. Nott, A. Hendrikx, M. Luke, S.K. Pal, J.J.M.C.H. de la Rosette. The clinical research office of the endourological society percutaneous nephrolithotomy global study: Outcomes in the morbidly obese patient- a case control analysis. Can Urol Assoc J. 2014 May;8(5-6):E393-7.
B.G. Muller, W. van den Bos, P.A. Pinto, J.J.M.C.H. de la Rosette. Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up. Curr Opin Urol. 2014 May;24(3):218-24.
L. Boccon-Gibod, P. Albers, J. Morote, H. van Poppel, J.J.M.C.H. de la Rosette, A. Villers, A. Malmberg, A. Neijber, F. Montorsi. Degarelix as an Intermittent Androgen Deprivation Therapy for One or More Treatment Cycles in Patients with Prostate Cancer. Eur Urol. 2014 Jun 18.
J.N. Cornu, S. Ahyai, A. Bachmann, J.J.M.C.H. de la Rosette, P. Gilling, C. Gratzke, K. McVary, G. Novara, H. Woo, S.A. Madersbacher. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction : An Update. Eur Urol. 2014 Jun 24.
K. van Renterghem, J.J.M.C.H. de la Rosette, H. Thijs, E. Wisanto, R. Achten, J. Ory, G. van Koeveringe. Alternative mechanisms for prostate-specific antigen elevation: a prospective analysis of 222 transurethral resections of prostate patients. World J Clin Urol 2014 July 24; 3(2): 144-151.
J. Cloutier, E.R. Cordeiro, G.M. Kamphuis, L. Villa, J. Letendre, J.J.M.C.H. de la Rosette, O. Traxer. The glue-clot technique: a new technique description for small calyceal stone fragments removal. Urolithiasis. 2014 Jul 9.
M. Westendarp, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Diagnosis of upper urinary tract tumors. A pending challenge. Arch Esp Urol. 2014 Jul;67(6):521-8. Spanish.
T. Bach, R. Muschter, T.R.W. Herrmann, T. Knoll, C.M. Scoffone, M.P. Laguna Pes, A. Skolarikos, P. Rischmann8, G. Janetschek, J.J.M.C.H. De la Rosette, U. Nagele, B. Malavaud, A. Breda, J. Palou, A. Bachmann, T. Frede, P. Geavlete, E. Liatsikos, P. Jichlinski, H.E. Schwaibold, P. Chlosta, A.G. Martov, A. Lapini, J. Schmidbauer, B. Djavan, A. Stenzl, M. Brausi and, J. J. Rassweiler. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives. BJU international, Jul 2014.
W. Artibani, V. Ficarra, B.J. Challacombe, C.C. Abbou, J. Bedke, R. Boscolo-Berto, M. Brausi, J.J.M.C.H. de la Rosette, S. Deger, L. Denis, G. Guazzoni, B. Guillonneau, J.P. Heesakkers, D. Jacqmin, T. Knoll, L. Martínez-Piñeiro, F. Montorsi, A. Mottrie, P.T. Piechaud, A. Rane, J. Rassweiler, A. Stenzl, J. Van Moorselaar, R.F. Van Velthoven, H. van Poppel, M. Wirth, P.A. Abrahamsson, K.F. Parsons KF. EAU policy on live surgery events. Eur Urol. 2014 Jul;66(1):87-97.
D. Opondo, S. Gravas, A. Joyce, M. Pearle, T. Matsuda, Y.H. Sun, D. Assimos, J. Denstedt, J.J.M.C.H. de la Rosette. Standardization of patient outcomes reporting in percutaneous nephrolithotomy. J Endourol. 2014 Jul;28(7):767-74.
M.T. Jenneke Bus, B.G. Muller, D.M. de Bruin, D.J. Faber, G.M. Kamphuis, T.G. van Leeuwen, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Volumetric inVivo Visualization of Upper Urinary Tract Tumors Using Optical Coherence Tomography: A Pilot Study. J Urol. 2013 Aug 13.
J. Baard, G.M. Kamphuis, M. Westendarp, J.J.M.C.H. de la Rosette. Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol. 2014 Aug 7.
G.M. Kamphuis, D.M. de Bruin, Th.M. de Reijke, J.J.M.C.H. de la Rosette. íSPIES--a novel approach to advanced endoscopic imaging. J Endourol. 2014 Aug;28(8):894-5.
M. Mischi, S. Turco, C. Lavini, K. Kompatsiari, J.J.M.C.H. de la Rosette, M. Breeuwer, H. Wijkstra. Magnetic resonance dispersion imaging for localization of angiogenesis and cancer growth. Invest Radiol. 2014 Aug;49(8):561-9.
J.J.M.C.H. de la Rosette. Prevention of kidney stones: a call for more evidence-based research. J Urol. 2014 Aug;192(2):325-6.
F. P. Daels, A. Gaizauskas, J. Rioja, A.K. Varshney, E. Erkan, Y. Ozgok, M. Melekos, J.J.M.C.H. de la Rosette. Age-related prevalence of diabetes mellitus, cardiovascular
Disease and anticoagulation therapy use in a urolithiasis population and their
Effect on outcomes: the Clinical Research Office of the Endourological Society
Ureteroscopy Global Study. World J Urol. 2014 Aug 26.
P.G. Wagstaff, A. Ingels, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna. Thermal ablation in renal cell carcinoma management : a comprehensive review. Curr Opin Urol. 2014 Sep;24(5):474-82.
M.T.J. Bus, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna, J.J.M.C.H. de la Rosette en Th. M. de Reijke. Urotheelcelcarcinoom in de hoge urinewegen. Ontwikkelingen in de diagnostiek, behandeling en follow-up. Nederlands Tijdschrift voor Urologie, september 2014.
A. Martov, S. Gravas, M. Etemadian, A. Unsal, G. Barusso, A. D'Addessi, A. Krambeck, J.J.M.C.H. de la Rosette. Postoperative Infection Rates in Patients with a Negative Baseline Urine Culture Undergoing Ureteroscopic Stone Removal: A Matched Case-Control Analysis on Antibiotic Prophylaxis from the CROES URS Global Study. J Endourol. 2014 Sep 5.
S.V. Kandasami, C. Mamoulakis, A.R. El-Nahas, T. Averch, O.L. Tuncay, A. Rawandale-Patil, L. Cormio, J.J.M.C.H. de la Rosette; on behalf of the CROES URS Global Study Group. Impact of Case Volume on Outcomes of Ureteroscopy for Ureteral Stones: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study.
W. van den Bos, D.M. de Bruin, B.G. Muller, I.M. Varkarakis, A.A. Karagiannis, P.J. Zondervan, M.P. Laguna Pes, D.P. Veelo, C.D. Savci Heijink, M.R. Engelbrecht, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol. BMJ Open. 2014 Oct 29;4(10):e006382.
2015:
C. Mamoulakis, J.J.M.C.H. de la Rosette. Bipolar Transurethral Resection of the Prostate: Darwinian Evolution of an Instrumental Technique. Urology. 2015 Feb 19.
A. Postema, P. Frinking, M. Smeenge, Th. M. de Reijke, J.J.M.C.H. de la Rosette, F. Tranquart, H. Wijkstra. Contrast Enhanced Ultrasound Parametric Imaging for the detection of Prostate Cancer. BJU Int. 2015 Mar 6.
M. Mischi, L. Demi, M. Smeenge, M.P. Kuenen, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra. Transabdominal contrast-enhanced ultrasound imaging of the prostate. Ultrasound Med Biol. 2015 Apr;41(4):1112-8.
A. Postema, T. Idzenga, M. Mischi, P. Frinking, J.J.M.C.H. de la Rosette, H. Wijkstra. Ultrasound modalities and quantification: developments of multiparametric ultrasonography, a new modality to detect, localize and target prostatic tumors. Curr Opin Urol. 2015 Feb 18.
A. Skolarikos, A.J. Gross, A. Krebs, D. Unal, E. Bercowsky, E. Eltahawy, B. Somani, J.J.M.C.H. Rosette. Outcomes of flexible ureteroscopy for solitary renal stones in the Clinical Research Office of Endourological Society URS Global study. J Urol. 2015 Feb 9.
B.G. Muller, W. van den Bos, M. Brausi, J.J. Fütterer, S. Ghai, P.A. Pinto, I.V. Popeneciu, Th.M. de Reijke, C. Robertson, J.J.M.C.H. de la Rosette, S. Scionti, B. Turkbey, H. Wijkstra, O. Ukimura, T.J. Polascik. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project. World J Urol. 2015 Jan 6.
G.M. Kamphuis, J. Baard, M. Westendarp, J.J.M.C.H. de la Rosette. Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol. 2015 Feb;33(2):223-33.
M.T. Bus, D.M. de Bruin, D.J. Faber, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, O. Traxer, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications. J Endourol. 2015 Feb;29(2):113-23.
J.J.M.C.H. de la Rosette, M.P. Laguna. Ureteric colic: evidence empowers responsible treatment. Lancet. 2015 May 18. pii: S0140-6736(15)60965-5.
O. Traxer, G. Wendt-Nordahl, H. Sodha, J. Rassweiler, S. Meretyk, A. Tefekli, F. Coz, J.J.M.C.H. de la Rosette. Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol. 2015 May 14.
S.G. Schalk, L. Demi, M. Smeenge, D.M. Mills, K.D. Wallace, J.J.M.C.H. de la Rosette, H. Wijkstra, M. Mischi. 4-D spatiotemporal analysis of ultrasound contrast agent dispersion for prostate cancer localization: a feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control. 2015 May;62(5):839-51.
M. Westendarp, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna. [Advances in ultrasound techniques for the diagnosis and staging of prostate cancer. Elastography, Doppler ultrasound, ultrasound contrast media, ultrasound quantification media and MRI fusion]. Arch Esp Urol. 2015 Apr;68(3):307-15. Spanish.
P.G. Wagstaff, D.M. de Bruin, P.J. Zondervan, C.D. Savci Heijink, M.R. Engelbrecht, O.M. van Delden, T.G. van Leeuwen, H. Wijkstra, J.J.M.C.H. de la Rosette, M.P. Laguna. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol. BMC Cancer. 2015 Mar 22;15:165.
P.G. Wagstaff, A. Swaan, A. Ingels, P.J. Zondervan, O.M. van Delden, D.J. Faber, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, D.M. de Bruin, M.P. Laguna. In vivo, percutaneous, needle based, optical coherence tomography of renal masses. J Vis Exp. 2015 Mar 30;(97).
H. Zarga, T.D. Atwell, J.A. Cadeddu, J.J.M.C.H. de la Rosette, G. Janetschek, J.H. Kaouk, S.F. Matin, T.J. Polascik, K. Zargar-Shoshtari, R.H. Thompson. Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol. 2015 Mar 25. pii: S0302-2838(15)00246-8.
A. Postema, M. Mischi, J.J.M.C.H. de la Rosette, H. Wijkstra. Multiparametric ultrasound in the detection of prostate cancer: a systematic review. World J Urol. 2015 Mar 12.
A. Postema, P. Frinking, M. Smeenge, Th. M. de Reijke, J.J.M.C.H. de la Rosette, F. Tranquart, H. Wijkstra. Contrast Enhanced Ultrasound Parametric Imaging for the detection of Prostate Cancer. BJU Int. 2015 Mar 6.
C.J. Arum, J.J.M.C.H. de la Rosette. Current diagnostics and follow-up for nonmuscle-invasive bladder cancer: are we "as good as it gets"? J Endourol. 2015 Mar;29(3):260-2.
P.G. Wagstaff, D.M. de Bruin, W. van den Bos, A. Ingels, M.J. van Gemert, P.J. Zondervan, R.M. Verdaasdonk, K.P. van Lienden, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna. Irreversible electroporation of the porcine kidney: Temperature development and distribution. Urol Oncol. 2015 Apr;33(4): 168.e1-7.
B.G. Muller, J.H. Shih, S. Sankineni, J. Marko, S. Rais-Bahrami, A. George, J.J.M.C.H. de la Rosette, M.J. Merino, B.J. Wood, P. Pinto, P.L. Choyke, B. Turkbey. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology. 2015 Jun 18:142818.
A. Skolarikos, J. Rassweiler, J.J.M.C.H. de la Rosette, G.Alivizatos, C. Scoffone, R.M. Scarpa, M. Schulze, C. Mamoulakis. Safety and efficacy of bipolar versus monopolar transurethral resection of the prostate in patients with large prostates or severe lower urinary tract symptoms: Post hoc analysis of a European multicenter randomized controlled trial. J Urol. 2015 Aug 26. pii: S0022-5347(15)04686-8.
J.J.M.C.H. de la Rosette, M. Elhilali, S. Naito, D. Unal, H. Razvi, E. Liatsikos, A. Bachmann, A. Tubaro, G. Alivizatos, S.K. Mak, G. Badlani, E. Eltahawy, C. Wong, M. Telich Vidal, A.Te, F. d'Ancona, C.J. Arum, J. Gutierrez; Clinical Research Office of the Endourological Society Global GreenLight Laser Study Group. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patients. Int J Urol. 2015 Aug 25.
W. van den Bos, D.M. de Bruin, R.R. Jurhill, C.D. Savci-Heijink , B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna-Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette . The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol. 2015 Aug 22.
B.G. Muller, A. Kaushal, S. Sankineni, E. Lita, A. Hoang, A.K. George, S. Rais-Bahrami, J. Kruecker, P. Yan, S. Xu, J.J.M.C.H. de la Rosette, M.J. Merino, B.J. Wood, P.A. Pinto, P.L. Choyke, B. Turkbey. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion-assisted biopsy for the diagnosis of local recurrence after radical prostatectomy. Urol Oncol. 2015 Aug 7. pii: S1078-1439(15)00263-X.
D. Assimos, A. Crisci, D. Culkin, W. Xue, A. Roelofs, M. Duvdevani, M. Desai, J.J.M.C.H. de la Rosette; CROES URS Global Study Group. Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int. 2015 Aug 3.
W. van den Bos, B.G. Muller, D.M. de Bruin, A.L. de Castro Abreu , C. Chaussy, J.A. Coleman, A. Finelli, I.S. Gill, M. E. Gross, S.F. Jenniskens, F. Kahmann, M.P. Laguna-Pes, A.R. Rastinehad, L.A. Simmons, T. Sulser, A. Villers, J.F. Ward, J.J.M.C.H. de la Rosette. Salvage ablative therapy in prostate cancer: International multidisciplinary consensus on trial design. Urol Oncol. 2015 Jul 28. pii: S1078-1439(15)00324-5.
B.G. Muller, D.M. de Bruin, W. van den Bos, M.J. Brandt, J.F. Velu, M.T. Bus, D.J. Faber, D. Savci, P.J. Zondervan, Th.M. de Reijke, M.P. Laguna-Pes, J.J.M.C.H. de la Rosette, T.G. van Leeuwen. Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography. J Med Imaging (Bellingham). 2015 Jul;2(3):037501.
E.D. Geijsen, Th.M. de Reijke, C.C. Koning, P.J. Zum Vörde Sive Vörding, J.J.M.C.H. de la Rosette, C.R. Rasch, R.M. van Os, J. Crezee. Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study. J Urol. 2015 Jul 2. pii: S0022-5347(15)04307-4.
R. Miano, A. Asimakopoulos, R. Da Silva, P. Bove, S. Jones, J.J.M.C.H. De La Rosette, F. Kim. Focal therapy for prostate cancer: current status and future perspectives. Minerva Urol Nefrol. 2015 Sep;67(3):263-80.
J. Denstedt, J.J.M.C.H. de La Rosette (red.): Stone Disease.
Glasgow: Société Internationale d'Urologie (SIU), 2015. -- 523p. -- ISBN 978-0-9877465-8-0.
A. Postema, T. Idzenga, M. Mischi, P. Frinking, J.J.M.C.H. de la Rosette, H. Wijkstra: Ultrasound modalities and quantification: developments of multiparametric ultrasonography, a new modality to detect, localize and target prostatic tumors. Current opinion in urology 25(3), 2015, p.191-197.
S.G. Schalk, A. Postema, T.A. Saidov, L. Demi, M. Smeenge, J.J.M.C.H. de La Rosette, H. Wijkstra, M. Mischi: 3D surface-based registration of ultrasound and histology in prostate cancer imaging. Computerized medical imaging and graphics 47, 2015, p.29-39.
M. Westendarp, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, M.P. Laguna: Avances en las Técnicas Ecográficas para el diagnóstico y estadiaje del cáncer de próstata. Elastografía, Ecografía doppler, Contrastes Ecográficos, Métodos de Cuantificación ecográfica y fusión con Resonancia Magnética Nuclear. Archivos Espanoles de urologia 68(3), 2015, p.307-315.
2016:
Saidov T, Heneweer C Kuenen M von Broich-Oppert J, Wijkstra H, de la Rosette J, Mischi M. Fractal Dimension of Tumor Microvasculature by DCE-US: Preliminary Study in Mice. Ultrasound Med Biol 2016 Dec;42(12):2852-2863
H. Zargar, T.D. Atwell, J.A. Cadeddu Jeffrey, J.J.M.C.H. de la Rosette, G. Janetschek, J.H. Kaouk, S.F. Matin, T.J. Polascik Thomas, K. Zargar-Shoshtari, R. Thompson. Houston: Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol 69(1), 2016, p.116-128.
P.G. Wagstaff, A. Ingels, D.M. de Bruin, M. Buijs, P.J. Zondervan, C.D. Savci Heijink, O.M. van Delden, D.J. Faber, T.G. van Leeuwen, R. J. van Moorselaar, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Percutaneous Needle Based Optical Coherence Tomography for the Differentiation of Renal Masses: a Pilot Cohort. J Urol. 2016 May;195(5):1578-85.
A.W. Postema, Th.M. de Reijke, O. Ukimura, W. Van den Bos, A.R. Azzouzi, E. Barret, D. Baumunk, A. Blana, A. Bossi, M. Brausi, J.A. Coleman, S. Crouzet, J. Dominguez-Escrig, S. Eggener, R. Ganzer, S. Ghai, I.S. Gill, R.T. Gupta, T.O. Henkel, M. Hohenfellne, J.S. Jones, F. Kahmann, C. Kastner, K.U. Köhrmann, G. Kovacs, R. Miano, R.J. van Moorselaar, N. Mottet, L. Osorio, B.R. Pieters, T.J. Polascik, A.R. Rastinehad, G. Salomon, R. Sanchez-Salas, M. Schostak, L. Sentker, K.J. Tay, I.M. Varkarakis, A. Villers, J. Walz, J.J.M.C.H. De la Rosette. Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project. World J Urol. 2016 Oct;34(10):1373-82.
G.M. Kamphuis, D.M. de Bruin, M.J. Brandt, T. Knoll, P. Conort, A. Lapini, J. Dominguez-Escrig, J.J.M.C.H. de la Rosette: Comparing Image Perception of Bladder Tumours in Four Different Storz Professional Image Enhancement System (SPIES) Modalities using the íSPIES App. J Endourol 2016 May;30(5):602-8.
P. Zondervan, K.P. Van Lienden, O.M. van Delden, J.J.M.C.H. de la Rosette, P. Laguna. Preoperative Decision Making for Nephron Sparing Procedure in the Renal Mass :Time for Using Standard Tools? J Endourol. 2016 Jan;30(1):128-34
W. van den Bos, D.M. de Bruin, A. van Randen, M.R. Engelbrecht, A.W. Postema, B.G. Muller, I.M. Varkarakis, A. Skolarikos, C.D. Savci-Heijink, R.R. Jurhill, P.J. Zondervan, M.P. Laguna Pes, H. Wijkstra, T.M. de Reijke, J.J.M.C.H. de la Rosette. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol. 2016 Jul;26(7):2252-60.
D.M. de Bruin, M. Broekgaarden, M.J.C. van Gemert., M. Heger, J.J.M.C.H. de La Rosette, T.G. van Leeuwen, D.J. Faber: Assesment of apoptosis induced changes in scattering using optical coherence tomography. In: JOURNAL OF BIOPHOTONICS 2016 Sep;9(9):913-23.
K.R. Ghani, S. Andonian, M. Bultitude, M. Desai, G. Giusti, Z. Okhunov, G.M. Preminge, J.J.M.C.H. de la Rosette. Percutaneous Nephrolithotomy: Update, Trends, and FutureDirections. Eur Urol. 2016 Feb 11. pii: S0302-2838(16)00166-4.
A. Skolarikos, J. Rassweiler, J.J.M.C.H. de la Rosette, G. Alivizatos, C. Scoffone, R.M. Scarpa, M. Schulze, C. Mamoulakis. Safety and Efficacy of Bipolar Versus Monopolar Transurethral Resection of the Prostate in Patients with Large Prostates or Severe Lower Urinary Tract Symptoms: Post Hoc Analysis of a European Multicenter Randomized Controlled Trial. J Urol. 016 Mar;195(3):677-84.
W. van den Bos, H.J. Scheffer, J.A. Vogel, P.G. Wagstaff , D.M. de Bruin, M.C. de Jong, M.J. van Gemert, J.J.M.C.H. de la Rosette, M.R. Meijerink, J.H. Klaessens, R.M. Verdaasdonk. Thermal Energy during Irreversible Electroporation and the Influence of Different Ablation Parameters. J Vasc Interv Radiol. 2016 Mar;27(3):433-43.
B.G. Muller, D.M. de Bruin, M.J. Brandt, W. van den Bos, S. van Huystee, D.J. Faber, D. Savci, P.J. Zondervan, Th.M. de Reijke, M.P. Laguna-Pes, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Prostate cancer diagnosis by optical coherence tomography: First results from a needle based optical platform for tissue sampling. J Biophotonics. 2016 May;9(5):490-8.
M.J. Scheltema, W. van den Bos, D.M. de Bruin, H. Wijkstra, M.P. Laguna Pes, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial. BMC Cancer. 2016 May 5;16(1):299.
F. Frauscher, J.J.M.C.H. de la Rosette. Editorial Comment. J Urol. 2016 Apr 25. pii: S0022-5347(16)30208-7.
S. Naito, F. Algaba, M. Babjuk, R.T. Bryan , Y.H. Sun, L. Valiquette, J.J.M.C.H. de la Rosette. CROES Narrow Band Imaging Global Study Group. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Eur Urol. 2016 Sep;70(3):506-15
P.J. Zondervan, P.G. Wagstaff, M.M. Desai, D.M. de Bruin, A.F. Fraga, B.A. Hadaschik, J. Köllermann, U.B. Liehr, S.A. Pahernik, H.P. Schlemmer, J.J. Wendler, F. Algaba, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Follow-up after focal therapy in renal masses: an international multidisciplinary Delphi consensus project. World J Urol. 2016 Dec;34(12):1657-1665
E.I. Liem, H. Crezee, J.J.M.C.H. de la Rosette, Th.M. de Reijke. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature andrecommendations. Int J Hyperthermia. 2016 Apr 7:1-11.
A. Wright, N. Rukin, D. Smith, J.J.M.C.H. De la Rosette, B.K. Somani. 'Mini, ultra, micro' - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques. Ther Adv Urol. 2016 Apr;8(2):142-6.
W. van den Bos, R.R. Jurhill, D.M. de Bruin, C.D. Savci-Heijink, A.W. Postema, P.G. Wagstaff, B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Histopathological Outcomes after Irreversible Electroporation in Prostate Cancer: Results of an Ablate and Resect Study. J Urol. 2016 Aug;196(2):552-9.
G. Roberts, D. Opondo, L. Nott, H. Razvi, J.J.M.C.H. de la Rosette, D. Beiko. Do urologists follow the golden rule? A global urolithiasis management study by the Clinical Research Office of the Endourological Society. Can Urol Assoc J. 2016 Jan-Feb;10(1-2):50-4.
G.M. Kamphuis, D.M. de Bruin, M.J. Brandt, T. Knoll, P. Conort, A. Lapini, J.L. Dominguez-Escrig, J.J.M.C.H. de la Rosette. Comparing Image Perception of Bladder Tumors in Four Different Storz Professional Image Enhancement System Modalities Using the íSPIES App. J Endourol. 2016 May;30(5):602-8.
P.J. Zondervan, K.P. van Lienden, O.M. van Delden, J.J.M.C.H. de la Rosette, M.P. Laguna. Preoperative Decision Making for Nephron-Sparing Procedure in the Renal Mass: Time for Using Standard Tools? J Endourol. 2016 Jan;30(1):128-34.
A.W. Postema, P.J. Frinking, M. Smeenge, Th.M. De Reijke, J.J.M.C.H. De la Rosette, F. Tranquart, H. Wijkstra. Dynamic contrast-enhanced ultrasound parametric imaging for the detection of prostate cancer. BJU Int. 2016 Apr;117(4):598-603.
P.J. Zondervan, M. Buijs, J.J.M.C.H. de la Rosette, O. van Delden, K. van Lienden, M.P. Laguna. Cryoablation of small kidney tumors. Int J Surg. 2016 Dec;36(Pt C):533-540
B.K. Somani, G. Giusti, Y. Sun, P.J. Osther, M. Frank, M. De Sio, B. Turna, J.J.M.C.H. de la Rosette. Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. World J Urol. 2017;35(4):675-681.
B.K. Somani, O. Aboumarzouk, O. Traxer, J. Baard, G. Kamphuis, J.J.M.C.H. de la Rosette. Medical expulsive therapy for ureteral stones: where do we go from here? Nat Rev Urol. 2016; 13(10):608-12.
M.T. Bus, D.M. de Bruin, D.J. Faber, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna-Pes, T.G. van Leeuwen, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Optical Coherence Tomography as a Tool for in Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study for Diagnostic Accuracy. J Urol. 2016 Jul 27. pii: S0022-5347(16)30924-7.
A.W. Postema, M. Catellani, M.J. Scheltema, W. van den Bos, J.J.M.C.H. de la Rosette. Surveillance following Focal Therapy interventions. Arch Esp Urol. 2016. Jul;69(6):364-74.
M.J. Scheltema, W. van den Bos, P.G. Wagstaff, A.W. Postema, D.M. de Bruin, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Irreversible electroporation, a new modality in Focal Therapy for prostate cancer. Arch Esp Urol. 2016 Jul;69(6):337-44.
P.G. Wagstaff, M. Buijs, W. van den Bos, D.M. de Bruin, P.J. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Irreversible electroporation: state of the art. Onco Targets Ther. 2016 Apr 22; 9:2437-46.
D.M. de Bruin, M. Broekgaarden, M.J. van Gemert, M. Heger, J.J.M.C.H. de la Rosette, T.G. Van Leeuwen, D.J. Faber. Assesment of apoptosis induced changes in scattering using optical coherence tomography. J Biophotonics. 2016 Sep;9(9):913-23.
G. Schooneveldt, H.P. Kok, E. Balidemaj, E.D. Geijsen, F. van Ommen, J. Sijbrands,
A. Bakker, J.J.M.C.H. de la Rosette, M.C. Hulshof, Th.M. de Reijke, J. Crezee. Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling. Med Phys. 2016 Oct;43(10):5442.
G.M. Kamphuis, D.M. de Bruin, J. Fallert, M.H. Gultekin, Th.M. de Reijke, M.P. Laguna Pes, J.J.M.C.H. de la Rosette. Storz Professional Image Enhancement System: a new technique to improve endoscopic bladder imaging. Journal of Cancer Science&Therapy. Volume 8(3)071-077(2016) ISSN:1948-5956 JCST.
W. van den Bos, D.M. de Bruin, A. van Randen, M.R. Engelbrecht, A.W. Postema, B.G. Muller, I.M Varkarakis, A. Skolarikos, C.C. Savci-Heijink, R.R. Jurhill, P.J. Zondervan, M.P. Laguna Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol. 2016 Jul;26(7):2252-60.
W. van den Bos, D.M. de Bruin, R.R. Jurhill, C.D. Savci-Heijink, B.G. Muller, I.M. Varkarakis, A. Skolarikos, P.J. Zondervan, M.P. Laguna-Pes, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol. 2016 May;34(5):657-64.
D. Assimos, A. Crisci, D. Culkin, W. Xue, A. Roelofs, M. Duvdevani, M. Desai, J.J.M.C.H. de la Rosette; CROES URS Global Study Group. Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int. 2016 Apr;117(4):648-54.
J.H. Jaunarena, C. Cristallo, M.S. González, F.P. Daels, J.J.M.C.H. De la Rosette, M.P. Laguna. [Management of malignant ureteral obstruction.]. Arch Esp Urol. 2016 Oct;69(8):507-517. Spanish.
2017:
M.J. Scheltema, K.J. Tay, A.W. Postema, D.M. de Bruin, J. Feller, J.J. Futterer, A.K. George, R.T. Gupta, F. Kahmann, C. Kastner, M.P. Laguna, S. Natarajan, S. Rais-Bahrami, A.R. Rastinehad, T.M. de Reijke, G. Salomon, N. Stone, R. van Velthoven, R. Villani, A. Villers, J. Walz, T.J. Polascik, J.J.M.C.H. de la Rosette. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol.2017 ;35(5):695-701
B.G. Muller, A. Swaan, D.M. de Bruin, W. van den Bos, A.W. Schreurs, D.J. Faber, E.C. Zwartkruis, L. Rozendaal, A.N. Vis, J.A. Nieuwenhuijzen,R.J. van Moorselaar, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Customized Tool for the Validation of Optical Coherence Tomography in Differentiation of Prostate Cancer. Technol Cancer Res Treat. 2017 Feb;16(1):57-65.
A. Ingels, M. Hew, F. Algaba, O.J. de Boer, R.J. van Moorselaar, S. Horenblas, P. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study. World J Urol. 2017 Jan;35(1):81-87
S. Schalk, L. Demi, N. Bouhouch, M. Kuenen, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, T. Tjalkens, M. Mischi. Contrast-enhanced Ultrasound Angiogenesis Imaging by Mutual Information Analysis for Prostate Cancer Localization. IEEE Trans Biomed Eng. 2017;64:661-670.
S. Guven, A. Basiri, A.K. Varshney, I.A. Aridogan, H. Miura, M. White, M. Kilinc, J.J.M.C.H. de la Rosette. Examining Paediatric Cases From the CROES Ureteroscopy Global Study. Urology. 2017;101:31-37.
R. van Sloun, L. Demi, A. Postema, J.J.M.C.H. de la Rosette, H. Wijkstra, M. Mischi. Entropy of Ultrasound-Contrast-Agent Velocity Fields for Angiogenesis Imaging in Prostate Cancer. IEEE Trans Med Imaging. 2017;35:610-619.
A. Krambeck, N. Wijnstok, P. Olbert, G. Mitroi, S. Bariol, H.N. Shah, A.S. El-Abd, B. Onal, J.J.M.C.H. de la Rosette. The Influence of Body Mass Index on Outcomes in Ureteroscopy: Results from the Clinical Research Office of Endourological Society URS Global Study. J Endourol. 2017;31(1):20-26.
J.D. Legemate, S.P. Zanetti, J. Baard, G.M. Kamphuis, E. Montanari, O. Traxer, J.J.M.C.H. de la Rosette. Outcome from 5-year live surgical demonstrations in urinary stone treatment: are outcomes compromised? World J Urol. 2017;35(11):1745-1756.
M.T. Bus, D.M. de Bruin, G.M. Kamphuis, P.J. Zondervan, M.P. Laguna Pes, Th.M. de Reijke, T.G. van Leeuwen, J.J.M.C.H. de la Rosette. Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma. Minerva Urol Nefrol. 2017 Apr;69(2):159-165.
S. Doizi, G. Kamphuis, G. Giusti, K.H. Andreassen, T. Knoll, P.J. Osther, C. Scoffone,
D. Pérez-Fentes, S. Proietti, O. Wiseman, J.J.M.C.H. de la Rosette, Traxer O. First clinical evaluation of a new single-use flexible ureteroscope (LithoVue™): a European
prospective multicentric feasibility study. World J Urol. 2017;35(8):1269-1275.
G. Muir, J. Klecka, D.J. Culkin, G.H. Barusso, J. Kums, C. Brunken, G. Eure, C. Rioja Sanz, F. Gomez Sancha, M.M. Yildiz, J.J.M.C.H. de la Rosette; Group on behalf of the CROES GLS Study.. Comparison of GreenLight laser and transurethral resection of the prostate baseline characteristics and outcomes: lessons learned from the Clinical
Research Office of the Endourological Society GreenLight Laser Study. Minerva
Urol Nefrol. 2017;69(3):285-292.
M. Buijs, K.P. van Lienden, P.G. Wagstaff , M.J. Scheltema, D.M. de Bruin, P.J. Zondervan, O.M. van Delden, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, M.P. Laguna. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b). JMIR Res Protoc. 2017 Feb 16;6(2):e21
J. Baard, D.M de Bruin, P.J Zondervan, G. Kamphuis, J.J.M.C.H. de la Rosette, P. Laguna. Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nature Review;Urol.2017Mar;14(3):181-191
A. Ingels, M. Hew, F. Algaba, O.J. de Boer, R.J. van Moorselaar, S. Horenblas, P. Zondervan, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study. World J Urol. 2017 Jan;35(1):81-87.
M. Smeenge, F. Tranquart, C.K. Mannaerts, Th. M. de Reijke, M.J. van de Vijver, M.P. Laguna, S. Pochon, J.J.M.C.H. de la Rosette, H. Wijkstra. First-in-Human Ultrasound Molecular Imaging with a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study. Invest Radiol. 2017 Jul;52(7):419-427.
E.E. van der Toom, J.E. Verdone, C. Jun, D. Petrisor, S. Lim, J.J.M.C.H. de la Rosette, Th.M. de Reijke, M.A. Gorin, K.J. Pienta, D. Stoianovici. A surface tension magnetophoretic device for rare cell isolation and characterization. Med Oncol. 2017 Feb;34(2):22.
R.S. Mandalapu, M. Remzi, Th.M. de Reijke, V. Margulis, J. Palou, A. Kapoor, O. Yossepowitch, J. Coleman, O. Traxer, J.K. Anderson, J. Catto, J.J.M.C.H. de la Rosette, T. O'Brien, A. Zlotta, S.F. Matin. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World J Urol. 2017 Mar;35(3):355-365.
A.W. Postema, M.J. Scheltema, C.K. Mannaerts, R.J. Van Sloun, T. Idzenga, M. Mischi, M.R. Engelbrecht, J.J.M.C.H. de la Rosette, H. Wijkstra. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. BMC Urol. 2017 Apr 5;17(1):27.
J. Baard, J.E. Freund, J.J.M.C.H. de la Rosette, M.P. Laguna. New technologies for upper tract urothelial carcinoma management. Curr Opin Urol. 2017 Mar;27(2):170-175.
J.D. Legemate, N.J. Wijnstok, T. Matsuda, W. Strijbos, T. Erdogru, B. Roth, H. Kinoshita, J. Palacios-Ramos, R.M. Scarpa, J.J.M.C.H. de la Rosette. Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones. World J Urol. 2017;35(10):1497-1506.
K.T. Pace, T. Kroczak, N.J. Wijnstok, G.M. Kamphuis, T. Esen, C. Toutziaris, B. Silva,
J.J.M.C.H. de la Rosette. Same Session Bilateral Ureteroscopy for Multiple Stones:
Results from the CROES URS Global Study. J Urol. 2017 Jul;198(1):130-137.
A.Y. Muslumanoglu, S. Fuglsig, A. Frattini, G. Labate, R.B. Nadler, A. Martov, C. Wong, J.J.M.C.H. de la Rosette. Risks and Benefits of Postoperative Double-J Stent Placement
After Ureteroscopy: Results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study. J Endourol. 2017 May;31(5):446-451.
K.J. Tay, M.J. Scheltema, H.U. Ahmed, E. Barret, J.A. Coleman, J. Dominguez-Escrig, S. Ghai, J. Huang, J.S. Jones, L.H. Klotz, C.N. Robertson, R. Sanchez-Salas, S. Scionti,
A. Sivaraman, J.J.M.C.H. de la Rosette, T.J. Polascik. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus
Project. Prostate Cancer Prostatic Dis. 2017;20(3):294-299.
M.J. Scheltema, K.J. Tay, A.W. Postema, D.M. de Bruin, J. Feller, J.J. Futterer, A.K. George, R.T. Gupta, F. Kahmann, C. Kastner, M.P. Laguna, S. Natarajan, S. Rais-Bahrami, A.R. Rastinehad, Th.M. de Reijke, G. Salomon, N. Stone, R. van Velthoven, R. Villani, A. Villers, J. Walz, T.J. Polascik, J.J.M.C.H. de la Rosette. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. World J Urol. 2017 May;35(5):695-701.
E.I.M.L. Liem, J. Baard, E.C.C. Cauberg, M.T.J. Bus, D.M. de Bruin, M.P. Laguna Pes, J.J.M.C.H. de la Rosette, Th.M. de Reijke. Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer. Med Oncol. 2017 Sep 2;34(10):172.
J.D. Legemate, F.M. Gonzalez, A. Bouzouita, S. Li, C. McIlhenny, N.L. Miller, A. Saita, J.J.M.C.H. de la Rosette. Outcomes of ureterorenoscopic stone treatment in 301 patients with a solitary kidney. J Endourol. 2017 Aug 21.
S. Proietti, J.J.M.C.H. de la Rosette, B. Eisner, F. Gaboardi, C. Fiori, E. Kinzikeeva, L. Luciani, R. Miano, F. Porpiglia, M. Rosso, M. Sofer, O. Traxer, G. Giusti. Bilateral endoscopic surgery for renal stones: a systematic review of the literature. Minerva Urol Nefrol. 2017 Oct;69(5):432-445.
J.J.M.C.H. de la Rosette, J. Denstedt. Update from third international consultation on stone disease. World J Urol. 2017 Jul 18. F. Sanguedolce, G. Bozzini, B. Chew, P. Kallidonis, J.J.M.C.H. de la Rosette. The Evolving Role of Retrograde Intrarenal Surgery in the Treatment of Urolithiasis. Eur Urol Focus. 2017 Feb;3(1):46-55.
A.W. Postema, M.J. Scheltema, C.K. Mannaerts, R.J. Van Sloun, T. Idzenga, M. Mischi, M.R. Engelbrecht, J.J.M.C.H. De la Rosette, H. Wijkstra. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients. BMC Urol. 2017 Apr 5;17(1):27.
K.J. Tay, M.J. Scheltema, H.U. Ahmed, E. Barret, J.A. Coleman, J. Dominguez-Escrig, S. Ghai, J. Huang, J.S. Jones, L.H. Klotz, C.N. Robertson, R. Sanchez-Salas, S. Scionti, A. Sivaraman, J.J.M.C.H. de la Rosette, T.J. Polascik. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):294-299.
M.J. Scheltema, A.W. Postema, D.M. de Bruin, M. Buijs, M.R. Engelbrecht, M.P. Laguna, H. Wijkstra, Th.M. de Reijke, J.J.M.C.H. de la Rosette. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback. Diagn Interv Radiol. 2017;23(5):365-370.
J.D. Legemate, G.M. Kamphuis, J.E. Freund,J. Baard, S.P. Zanetti, M. Catellani,H.W. Oussoren, J.J. de la Rosette. Durability of Flexible Ureteroscopes: A Prospective Evaluation of Longevity, the Factors that Affect it, and Damage Mechanisms. Eur Urol Focus. 2018 Mar 10. pii: S2405-4569(18)30079-8. doi:10.1016/j.euf.2018.03.001.
J.D. Legemate,B. Baseskioglu, J. Dobruch, J. Gutierrez-Aceves,O. Negrete, C. Rioja
Sanz, M.M. Yildiz, J.J.M.C.H. de la Rosette. Ureteroscopic Urinary Stone Treatment
Among Patients With Renal Anomalies: Patient Characteristics and Treatment
Outcomes. Urology. 2017 Dec;110:56-62.
F. Sanguedolce, G. Bozzini, B. Chew, P. Kallidonis, J. de la Rosette. The Evolving
Role of Retrograde Intrarenal Surgery in the Treatment of Urolithiasis. Eur Urol
Focus. 2017 Feb;3(1):46-55
M.J. Scheltema,J.I. Chang,W. van den Bos,M. Böhm,W. Delprado,I. Gielchinsky,T.M. de
Reijke,J.J. de la Rosette,A.R. Siriwardana,R. Shnier,P.D. Stricker. Preliminary
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect
Residual Prostate Cancer Following Focal Therapy with Irreversible
Electroporation. Eur Urol Focus. 2017 Nov 1. pii: S2405-4569(17)30244-4.
2018:
Z. Zhao, J. Fan, Y. Liu, J. de la Rosette, G. Zeng. Percutaneous nephrolithotomy:
position, position, position! Urolithiasis. 2018 Feb;46(1):79-86.
M. Buijs,P.G.K. Wagstaff,D.M. de Bruin, P.J. Zondervan, C.D. Savci-Heijink,O.M. van
Delden,T.G. van Leeuwen,R.J.A. van Moorselaar, J.J.M.C.H. de la Rosette, M.P. Laguna Pes. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis. Eur Urol Focus. 2017 Oct 24. pii:
S2405-4569(17)30239-0.
R. Naspro,L.B. Lerner, R. Rossini,M. Manica, H.H. Woo,R.J. Calopedos,C.M. Cracco,
C.M. Scoffone, T.R. Herrmann, J.J. de la Rosette, J.N. Cornu, L.F. DA Pozzo. Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: where do we stand with current literature? Minerva Urol Nefrol. 2018 Apr;70(2):126-136.
Saussine C, Andonian S, Pacík D, Popiolek M, Celia A, Buchholz N, Sountoulides
P, Petrut B, de la Rosette JJMCH. Worldwide Use of Antiretropulsive Techniques:
Observations from the Clinical Research Office of the Endourological Society
Ureteroscopy Global Study. J Endourol. 2018 Apr;32(4):297-303.
G.S.M. Kammeijer, J. Nouta,J.J.M.C.H. de la Rosette,T.M. de Reijke,M. Wuhrer. An
In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen. Anal Chem.
2018 Apr 3;90(7):4414-4421
E.E. van der Toom,V.P. Groot,S.A. Glavaris,G. Gemenetzis,H.J. Chalfin,L.D. Wood,
C.L. Wolfgang, J.J.M.C.H. de la Rosette,T.M. de Reijke,K.J. Pienta. Analogous detection of circulating tumor cells using the AccuCyte(®) -CyteFinder(®) system and ISET system in patients with locally advanced and metastatic prostate cancer. Prostate. 2018 Mar;78(4):300-307.
E.I. Liem, J.E. Freund, J. Baard, D.M. de Bruin,M.P. Laguna Pes,C.D. Savci-Heijink,T.G. van Leeuwen,T.M. de Reijke,J.J. de la Rosette. Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies. JMIR Res Protoc. 2018 Feb7;7(2):e34
M.T.J. Bus,P. Cernohorsky,D.M. de Bruin,S.L. Meijer,G.J. Streekstra,D.J. Faber, G.M. Kamphuis, P.J. Zondervan,M. van Herk,M.P. Laguna Pes,M.J. Grundeken,M.J. Brandt , T.M. de Reijke, J.J.M.C.H. de la Rosette, T.G. van Leeuwen. Ex-vivo study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasound. J Med Imaging (Bellingham). 2018 Jan;5(1):017001.
R.R. Tourinho-Barbosa, J. de la Rosette, R. Sanchez-Salas. Prostate cancer multifocality, the index lesion, and the microenvironment. Curr Opin Urol. 2018;28(6):499-505.
BG Muller BG, RAA van Kollenburg, A Swaan, ECH Zwartkruis, MJ Brandt, LS Wilk, M. Almasian, AW Schreurs, DJ Faber, LR Rozendaal, AN Vis, JA Nieuwenhuijzen, J van Moorselaar, JJMCH de la Rosette, DM de Bruin, TG van Leeuwen. Needle-based optical coherence tomography for the detection of prostate cancer: a visual and quantitative analysis in 20 patients. J Biomed Opt. 2018 Aug;23(8):1-11
EIML Liem, JE Freund, CD Savci-Heijink, JJMCH de la Rosette, GM Kamphuis, J Baard, JC Liao, TG van Leeuwen, TM de Reijke, DM de Bruin. Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading. Eur Urol Focus. 2018 Jul 19. pii:S2405-4569(18)30178-0.
O Lodeizen, M de Bruin, S Eggener, S Crouzet, S Ghai, I Varkarakis, A. Katz, JL Dominguez-Escrig, S Pahernik, T de Reijke, J de la Rosette. Ablation energies for focal treatment of prostate cancer. World J Urol. 2018 Jun 25. doi: 10.1007/s00345-018-2364-x. [Epub ahead of print] PubMed PMID: 29943219.
A Swaan, CK Mannaerts, MJ Scheltema, JA Nieuwenhuijzen, CD Savci-Heijink, JJ de la Rosette, RJA van Moorselaar, TG van Leeuwen, TM de Reijke, DM de Bruin. Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A). JMIR Res Protoc. 2018 May 21;7(5): e132.
G Zeng, T Zhang, M Agrawal, X He, W Zhang, K Xiao, Li H, Li X, Xu C, S Yang, J de la Rosette, J Fan, W Zhu, K Sarica. Super-mini percutaneous nephrolithotomy (SMP) vs retrograde intrarenal surgery for the treatment of 1-2 cm lower-pole renal calculi: an international multicentre randomised controlled trial. BJU Int. 2018;122(6):1034-1040.
R. Sanchez-Salas, J. de la Rosette, TJ Polascik, A Carneiro, A Sivaraman, X Cathelineau , J Walz. Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients. Eur Urol. 2018;74(5)537-539:
MJ Scheltema, JI Chang, M. Böhm, W van den Bos, A Blazevski, I Gielchinsky, AMF Kalsbeek, PJ van Leeuwen, TV Nguyen, TM de Reijke, AR Siriwardana, JE Thompson, JJ de la Rosette, PD Stricker. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. World J Urol. 2018 Sep;36(9):1383-1389.
S Arver, C Stief, J de la Rosette, TH Jones, A Neijber, D Carrara. A new 2% testosterone gel formulation: a comparison with currently available topical preparations. Andrology. 2018 May;6(3):396-407
EIML Liem, M McCormack, ESY Chan, Y Matsui, P Geavlete, YD Choi, TM de Reijke, Y Farahat, BA Inman, JJMCH de la Rosette, S Naito. Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. Urol Oncol. 2018 Jul;36(7): 338.e1-338.e11.
A.Basiri, J.J. de la Rosette, S. Tabatabaei, H.H. Woo, M.P. Laguna, H. Shemshaki.Comparison of retropubic, laparoscopic and robotic radical prostatectomy: who is the winner? World J Urol. 2018 Apr;36(4):609-621.
J.D. Legemate, S.P. Zanetti, J.E. Freund, J. Baard, J.J.M.C.H. de la Rosette. Surgical teaching in urology: patient safety and educational value of 'LIVE' and 'SEMI-LIVE' surgical demonstrations. World J Urol. 2018 Oct;36(10):1673-1679
A. Aminsharifi, J. de la Rosette, T.J. Polascik. Focal therapy of prostate and kidney cancer. Curr Opin Urol. 2018 Nov;28(6):491-492
M.J. Scheltema, J.I. Chang, W. van den Bos, I. Gielchinsky, T.V. Nguyen, T.M. de Reijke, A.R. Siriwardana, M. Böhm, J.J.de la Rosette, P.D. Stricker. Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments. Diagn Interv Radiol. 2018 Sep;24(5):268-275
Johnston TJ, Baard J, de la Rosette J, Doizi S, Giusti G, Knoll T, Proietti S, Brehmer M, Emiliani E, Perez-Fentes D, Osther PJS, Seitz C, Neal N, Turney B, Hasan M, Traxer O, Wiseman O. Cent European J Urol 2018;71(4):453-61
Schooneveldt G, Kok HP, Bakker A, Geijsen ED, Rasch CRN, de la Rosette JJMCH, Hulshof MCCM, de Reijke TM, Crezee H. Int J Hyperthermia 2018;35(1):383-397
2019:
van der Toom EE, Axelrod HD, de la Rosette JJ, de Reijke TM, Pienta KJ, Valkenburg KC. Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies. Nat Rev Urol. 2019 Jan;16(1):7-22
Deng T, Chen Y, Liu B, Laguna MP, de la Rosette JJMCH, Duan X, Wu W, Zeng G. Systematic review and cumulative analysis of the managements for proximal impacted ureteral stones. World J Urol. 2019 Aug;37(8):1687-1701
Legemate JD Kamphuis GM, Freund JE, Baard J, Oussoren HW, Spijkerman IJ, de la Rosette JJ. Pre-use ureteroscope contamination after high-level disinfection: reprocessing effectiveness. J Urol. 2019 Jun;201(6):1144-1151
Freund JE, Liem EIML, Savci-Heijink CD, Baard J, Kamphuis GM, de la Rosette JJMCH, de Bruin DM. Confocal laser endomicroscopy for upper tract urothelial
carcinoma: validation of the proposed criteria and proposal of a scoring system
for real-time tumor grading. World J Urol. 2019 Oct;37(10):2155-2164
Van Luijtenaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, Kovacs G, Linder U, Loeb S, Margolis DJ, Marks LS, May S, McClure TD, Montironi R, Nour SG, Oto A, Polascik TJ, Rastinehad AR, de Reijke TM, Reijnen JS, de la Rosette JJMCH, Sedelaar JPM, Sperling DS, Salser EM, Ward JF, Villers A, Chai S, Futterer JJ. World J Urol. 2019 Oct;37(10):2147-2153
Zhao Z, Fan J, Sun H, Zhong W, Zhu W, Liu Y, Wu W, de la Rosette J, Del Pilar
Laguna Pes M, Zeng G. Recommended antibiotic prophylaxis regimen in retrograde
intrarenal surgery: evidence from a randomised controlled trial. BJU Int. 2019 Sep;124(3):496-503
Johnston TJ, Baard J, de la Rosette J, Doizi S, Giusti G, Knoll T, Proietti S, Brehmer M, Emiliani E, Pérez-Fentes D, Osther PJS, Seitz C, Neal N, Turney B, Hasan M, Traxer O, Wiseman O. A clinical evaluation of the new digital single-use flexible ureteroscope (UscopePU3022): an international prospective multicentered study. Cent European J Urol. 2018;71(4):453-461
Scheltema MJ, O'Brien TJ, van den Bos W, de Bruin DM, Davalos RV, van den Geld
CWM, Laguna MP, Neal RE 2nd, Varkarakis IM, Skolarikos A, Stricker PD, de Reijke
TM, Arena CB, de la Rosette J. Numerical simulation modeling of the irreversible
electroporation treatment zone for focal therapy of prostate cancer, correlation
with whole-mount pathology and T2-weighted MRI sequences. Ther Adv Urol. 2019 Jun
7;11:1756287219852305
2020:
Sandbergen L, Spriensma AS, de la Rosette JJ, Laguna MP. Health-related quality of life in localized renal masses: A matter of sparing nephrons or minimizing the incision? Urol Oncol. 2020 Feb;38(2):43.e1-43.e11
Baard J, Celebi M, de la Rosette J, Alcaraz A, Shariat S, Cormio L, Cavadas V, Laguna MP. Evaluation of Patterns of Presentation, Practice, and Outcomes of Upper Tract Urothelial Cancer: Protocol for an Observational, International, Multicenter, Cohort Study by the Clinical Research Office of the Endourology Society. JMIR Res Protoc. 2020 Jan 24;9(1):e15363
Ermis O, Somani B, Reeves T, Guven S, Pes PL, Chawla A, Hegde P, de la Rosette J.Definition, treatment and outcome of residual fragments in staghorn stones. J Urol. 2020 Apr;7(2):116-121
Kordan Y, Canda AE, Köseoğlu E, Balbay D, Laguna MP, de la Rosette J. Robotic-Assisted Simple Prostatectomy: A Systematic Review..J Clin Med. 2020 Jun 9;9(6):179
Liem EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, Kamphuis GM, Baard J, Liao JC, van Leeuwen TG, de Reijke TM, de Bruin DM. Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading..Eur Urol Focus. 2020 Jan 15;6(1):81-87
Pereira Azevedo N, Gravas S, de la Rosette J. Mobile Health in Urology: The Good, the Bad and the Ugly.J Clin Med. 2020 Apr 3;9(4):1016.
Correas JM, Halpern EJ, Barr RG, Ghai S, Walz J, Bodard S, Dariane C, de la Rosette J.World Advanced ultrasound in the diagnosis of prostate cancer. J Urol. 2020 Apr 18. doi: 10.1007/s00345-020-03193-0. Online ahead of print
Gravas S, Ahmad M, Hernández-Porras A, Furriel F, Alvarez-Maestro M, Kumar A, Lee KS, Azodoh E, Mburugu P, Sanchez-Salas R, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, Elliott S, de la Rosette J; Office of Education and SIU Board of Directors. World J Urol. 2020 Aug 29:1-7. doi: 10.1007/s00345-020-03417-3. Online ahead of print
Gravas S, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, de la Rosette J.Impact of COVID-19 on Urology Practice: A Global Perspective and Snapshot Analysis.J Clin Med. 2020 Jun 3;9(6):1730
Gravas S, Fournier G, Oya M, Summerton D, Scarpa RM, Chlosta P, Gkialas I, Xie LP, Rasyid N, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, de la Rosette J; SIU Board of Directors.Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines. Eur Urol Focus. 2020 Sep 15;6(5):1104-1110
de la Rosette J, Laguna P, Álvarez-Maestro M, Eto M, Mochtar CA, Albayrak S, Mendoza-Valdes A, Ong TA, Khadgi S, Al-Terki A, Bolton D, Gomez R, Klotz L, Kulkarni S, Tanguay S, Gravas S; Société Internationale d’Urologie Board of Directors. Cross-continental comparison of safety and protection measures amongst urologists during COVID-19Int J Urol. 2020 Nov;27(11):981-989.
Morselli S, Liaci A, Nicoletti R, Pecoraro A, Gemma L, Polverino P, Zaccaro C, Sebastianelli A, Serni S, Laguna P,de La Rosette JJMC, Gravas S, Gacci M The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):724-726.
Kashi AH,de la Rosette J, Amini E, Abdi H, Fallah-Karkan M, Vaezjalali M Urinary Viral Shedding of COVID-19 and its Clinical Associations: A Systematic Review and Meta-analysis of Observational Studies. Urol J. 2020 Sep 5;17(5):433-441.
Yamada Y, Ukimura O, Kaneko M, Matsugasumi T, Fujihara A, Vourganti S, Marks L, Sidana A, Klotz L, Salomon G,de la Rosette J. Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World J Urol. 2020 Jul 29. doi: 10.1007/s00345-020-03366-x. Online ahead of print.
Guddeti RS, Hegde P, Chawla A,de la Rosette JJMCH, Laguna Pes MP, Kapadia A Super-mini percutaneous nephrolithotomy (PCNL) vs standard PCNL for the management of renal calculi of <2cm: a randomised controlled study. BJU Int. 2020 Aug;126(2):273-279.
Michel MC, Schumacher H, Mehlburger L,de la Rosette JJMCH.Factors Associated With Nocturia-Related Quality of Life in Men With Lower Urinary Tract Symptoms and Treated With Tamsulosin Oral Controlled Absorption System in a Non-Interventional Study. Front Pharmacol. 2020 Jun 4;11:816
Lebastchi AH, George AK, Polascik TJ, Coleman J,de la Rosette J, Turkbey B, Wood BJ, Gorin MA, Sidana A, Ghai S, Tay KJ, Ward JF, Sanchez-Salas R, Muller BG, Malavaud B, Mozer P, Crouzet S, Choyke PL, Ukimura O, Rastinehad AR, Pinto PA. Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus. Eur Urol. 2020 Sep;78(3):371-378
Amaresh M, Hegde P, Chawla A,de la Rosette JJMCH, Laguna MP, Kriplani A. Safety and efficacy of superior calyceal access versus inferior calyceal access for pelvic and/or lower calyceal renal calculi- a prospective observational comparative study.World J Urol. 2020 Aug 31. doi: 10.1007/s00345-020-03409-3. Online ahead of print.